cephalosporin c has been researched along with vancomycin in 538 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 96 (17.84) | 18.7374 |
| 1990's | 126 (23.42) | 18.2507 |
| 2000's | 122 (22.68) | 29.6817 |
| 2010's | 159 (29.55) | 24.3611 |
| 2020's | 35 (6.51) | 2.80 |
| Authors | Studies |
|---|---|
| Gavan, TL; McHenry, MC | 1 |
| Minasova, GS; Smekuna, FA; Zak, IR | 1 |
| Winter, RE | 1 |
| Granatek, AP; Nunning, BC; Ricci, RA | 1 |
| Eichenwald, HF; McCracken, GH | 1 |
| Liu, C | 2 |
| Watanakunakorn, C | 2 |
| Leedom, JM; Overturf, GD; Underman, AE | 1 |
| Fowst, G; Nessi, R | 1 |
| Moreland, N; Siebert, WT; Williams, TW | 1 |
| Cunha, BA; Quintiliani, R | 1 |
| Laverdiere, M; Peterson, P; Sabath, LD; Verhoef, J; Williams, DN | 1 |
| Cobbs, CG; Holley, HP; Reymann, MT | 1 |
| Hewitt, WL; McHenry, MC | 1 |
| Benn, R | 1 |
| Finegold, SM | 1 |
| Amalfitano, G; Canepari, P; Fontana, R; Ligozzi, M; Piacentini, E | 1 |
| Hanberger, H | 1 |
| Alonso, T; Liñares, J; Pérez, JL | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Mason, NA; O'Brien, MA | 1 |
| Anzai, T; Iijima, T; Ishikawa, S; Kamoshita, Y; Obayashi, T; Otaki, A; Saito, A; Sakata, Y; Suzuki, M; Yanagisawa, H | 1 |
| Simon, C; Simon, M | 1 |
| Bodnárová, J; Fuchsberger, P; Gocár, M; Koza, I; Krcméry, V; Salát, T; Sobota, R; Svec, J | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Suzuki, Y; Yokota, N | 1 |
| Reed, RL | 1 |
| Henry, SL; Mangino, P; Popham, GJ; Seligson, D | 1 |
| Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
| Mattie, H | 1 |
| Bayer, AS; Nelson, RJ; Slama, TG | 1 |
| Akalin, HE; Baykal, M | 1 |
| Baker, CJ; Butler, KM; Cheek, WR; Edwards, MS; Laurent, JP; Mason, EO | 1 |
| Bemis, AT; Norton, JA; Reynolds, J; Smith, JW; Treger, T; Wheat, LJ | 1 |
| Traub, WH | 1 |
| Waldvogel, FA | 1 |
| Chandrasekar, PH; Levine, DP; Price, S | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Feingold, DS; Wagner, RF | 1 |
| Finch, R; Whitby, M | 1 |
| Davies, AJ; Stone, JW | 1 |
| Brooks, GF; Davis, RH; Lammel, CJ; Mordenti, JJ | 1 |
| Shanson, DC | 1 |
| Bourgault, AM; Bryan, L; Harding, GJ; Henry, DA; Hoban, DJ; Horsman, GB; Marrie, T; Smith, JA; Turgeon, P | 1 |
| Gray, JL; Medoff, G; Smith, MD; Woodward, RS | 1 |
| Pankey, GA; Valainis, GT | 1 |
| Wong, HB | 1 |
| Dajani, AS; Thirumoorthi, MC | 1 |
| Rouan, MC | 1 |
| Amin, NM | 1 |
| Darrell, JH | 1 |
| Benner, EJ; Kayser, FH | 1 |
| Koenig, MG | 1 |
| Hermans, PE; Wilkowske, CJ | 1 |
| Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
| Russell, AD | 1 |
| Ericsson, HM; Sherris, JC | 1 |
| Pitts, JC | 1 |
| Craig, CP; Gordon, SL; Greer, RB | 1 |
| Gonçalves, AJ; Moreira, AS; Suzuki, LE | 1 |
| Kovnat, P; Labovitz, E; Levison, SP | 1 |
| Johnson, AH | 1 |
| Hoppes, WL; Lerner, PI | 1 |
| Ward, JB | 1 |
| Hewitt, WL; Keys, TF | 1 |
| Graham, RC | 1 |
| DeVoe, AG | 1 |
| Di Nola, F | 1 |
| Wise, RI | 1 |
| Vacek, V | 1 |
| MacIlwaine, WA; Mandell, GL; Sande, MA | 1 |
| Lerner, PI | 1 |
| von Oldershausen, HF | 1 |
| Perkins, HR | 2 |
| Torbochkina, LI | 1 |
| Sanford, JP; Swenson, RM | 1 |
| Finland, M; McDonald, A; Toala, P; Wilcox, C | 1 |
| Fomina, IP; Lobuseva, AN | 1 |
| Browder, HP; Harrison, EF; Tavormina, PA; Zygmunt, WA | 1 |
| Ross, S | 1 |
| Hermans, PE; Martin, WJ; Washington, JA | 1 |
| Strominger, JL; Tipper, DJ | 1 |
| Everett, ED; Strausbaugh, LJ | 1 |
| Hodges, GR; Snavely, SR | 1 |
| Danziger, LH; Hau, T; Nishikawa, R | 1 |
| Johnson, CA; Rogge, M; Zimmerman, SW | 1 |
| Thompson, RL; Wright, AJ | 1 |
| Janknegt, R; Koks, CH | 1 |
| Aronoff, SC; Scoles, PV | 1 |
| Coppens, L; Hanson, B; Klastersky, J | 1 |
| Hansen, BG | 1 |
| Chandrasekar, PH; LeFrock, JL; Rolston, KV | 1 |
| Kroeger, DC; Montgomery, EH | 1 |
| Fenton, P | 1 |
| Nord, CE; Nordbring, F | 1 |
| Bartlett, JG | 1 |
| Turck, M | 1 |
| Tedesco, FJ | 1 |
| Coppens, L | 1 |
| Moellering, RC; Murray, BE | 1 |
| Dismukes, WE | 1 |
| Harvey, K; Pavillard, R | 1 |
| Geraci, JE; Giuliani, ER; Wilson, WR | 1 |
| Wenzel, RP | 1 |
| Scheld, WM | 1 |
| Agbo, P; Carnot, JF; Cayroche, P; Chalvon-Demersay, A; Hacquard, B; Mariani, P | 1 |
| Badoual, J; Bergeret, M; Bingen, E; Brahimi, N; Doit, C; Gendrel, D; Raymond, J | 1 |
| Galloway, KP; Henry, SL | 1 |
| Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES | 1 |
| Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
| al Khayat, R; Michel, C; Mignon, F; Siohan, P; Viron, B | 1 |
| Schwartz, MT; Tunkel, AR | 1 |
| Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC | 1 |
| Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
| Bastien, O; Brun, Y; Celard, M; Estanove, S; Etienne, J; Fleurette, J; Lehot, JJ | 1 |
| de Meyer, A; Lauwers, S; Piérard, D | 1 |
| Nicolau, DP; Nightingale, CH; Onyeji, CO; Tessier, PR | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N | 1 |
| Bingen, E; Bourrillon, A | 1 |
| Bannwarth, B; Demotes-Mainard, F; Labat, L; Vinçon, G | 1 |
| Swartz, MN | 1 |
| Klugman, KP | 1 |
| Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
| DeVaro, JM; Donahue, SP; Eller, AW; Jewart, BH; Kowalski, RP | 1 |
| Freifeld, AG | 1 |
| Klastersky, J | 1 |
| Grøndahl, TO; Langmoen, IA | 1 |
| Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
| Klaus, G; Mehls, O; Müller-Wiefel, D; Schaefer, F | 1 |
| Cabellos, C; Fernández, A; Gudiol, F; Martinez-Lacasa, J; Martos, A; Tubau, F; Viladrich, PF | 1 |
| Chesney, PJ; Davis, Y; English, BK; Wang, WC | 1 |
| Aguilar, HE; Drews, C; Gardner, S; Grossniklaus, H; Meredith, TA; Sawant, AD | 1 |
| Fellows, DG; Rosenbaum, AE; Thomas, PS; Vakharia, S; Wang, JS | 1 |
| McCracken, GH; París, MM; Ramilo, O | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Byl, B; Jacobs, F; Struelens, MJ; Thys, JP | 1 |
| Barreiro Casal, G; Cilleruelo Ortega, MJ; García López, M; Martín Fontelos, P; Mellado Peña, MJ; Pérez Jurado, ML; Villota Arrieta, J | 1 |
| Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Hasegawa, H; Kanai, A; Otoguro, K; Shimizu, K | 1 |
| Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
| Culver, D; Danzing, L; Edwards, J; Gaynes, R; Stroud, L | 1 |
| Chesney, PJ; English, BK | 1 |
| Suppola, JP; Vaara, M; Valtonen, VV; Volin, L | 1 |
| Hafner, A; John, J; Riley, LW; Roberts, RB; Tornieporth, NG | 1 |
| Barbour, AG; Dever, LL; Jorgensen, JH; Kazragis, RJ | 1 |
| Dahners, LE; Edin, ML; Lester, GE; Lindsey, RW; Miclau, T | 1 |
| Bergeret, M; Raymond, J; Vedel, G | 2 |
| Garcia, R; Raad, I | 1 |
| Allende, H; Almirante, B; Capdevila, JA; Crespo, E; Gavaldà, J; Laguarda, M; Otero, J; Pahissa, A; Pigrau, C; Ruiz, I | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Khan, J; Lucey, DR; Park, MK; Stock, F | 1 |
| Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A | 1 |
| Aiuto, LT; Barone, SR; Black, K; Boxer, RA; Krilov, LR | 1 |
| Ohsawa, R; Okazaki, N; Sata, S; Suzuki, R; Wada, A; Watanabe, H; Watanabe, Y; Yamai, S | 1 |
| Major, P; Marton, A | 1 |
| Kovalik, EC; Schwab, SJ | 1 |
| Barre, J; Bingen, EH; Bonacorsi, S; Bourrillon, A; Cohen, R; Doit, C | 1 |
| Idezuki, Y; Iwai, S; Kobayashi, H; Konishi, T; Shimada, K; Shinagawa, N; Yamaguchi, K | 1 |
| Barkholt, L; Edlund, C; Nord, CE; Olsson-Liljequist, B | 1 |
| de Pablos, M; Lezaun, MJ; López-Bayón, J; Michaus, ML; Pérez-Díaz, L | 1 |
| Fraise, AP | 1 |
| Burnakis, TG | 1 |
| Degener, JE; Kosterink, JG; Mulder, JG | 1 |
| Campochiaro, PA; Haller, JA; Santos, A; Zimmer-Galler, IE | 1 |
| Ashkenazi, S; Rachmel, A; Samra, Z; Steinberg, T | 1 |
| Jones, RN; Marshall, SA; Pfaller, MA | 1 |
| Eliott, D; Lewis, JM | 1 |
| Charlton, JF; Dalla, KP; Kniska, A | 1 |
| Abbar, H; Bascoulard, M; Lemasson, P; Mbuila, C; Ntima-Nsiemi, K | 1 |
| Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
| Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR | 1 |
| Birmingham, MC; Carr, JR; Cumbo, TJ; Hyatt, JM; Paladino, JA; Schentag, JJ; Zimmer, GS | 1 |
| Vuorisalo, S | 1 |
| Pokela, R; Syrjälä, H; Vuorisalo, S | 1 |
| Ambergen, AW; Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Choi, EH; Lee, HJ | 1 |
| Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB | 1 |
| Amorena, B; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Aboleneen, HI; Backes, DW; Simpson, JA | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Larocque, D | 1 |
| Covington, LA; Eck, JC; Hodges, SD; Humphreys, SC; Kurzynske, NG | 1 |
| Beilman, GJ; Dahms, RA; Dunn, DL; Johnson, EM; Lee, JT; Statz, CL | 1 |
| Klaus, G; Mehls, O; Müller-Wiefel, DE; Schaefer, F | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Leader, WG; Stamatakis, MK; Tracy, TS | 1 |
| Cha, JH; Chang, MH; Cho, YS; Choi, KI; Jeong, DY; Kim, D; Kim, Y; Kim, YH; Koh, HY; Kong, JY; Pae, AN; Park, SH; Park, SY | 1 |
| Fleer, A; Gerards, LJ; Jones, ME; Krediet, TG | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Bourrillon, A | 1 |
| Bergman, R; Friedman-Birnbaum, R; Sprecher, E | 1 |
| Bartlett, ST; Keay, S; McCarter, RJ; Morris, JG; Oldach, DW; Pfundstein, J; Qaiyumi, SQ; Roghmann, MC; Schwalbe, RS; Schweitzer, E | 1 |
| Filka, J; Huttova, M; Kralinsky, K; Krcmery, V; Sagat, T; Tuharsky, J | 1 |
| Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
| Klugman, KP; Madhi, SA | 1 |
| Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
| Harjula, AL; Ikonen, TE; Sahlman, AE; Salminen, US; Valtonen, VV; Viljanen, TU | 1 |
| Dowell, SF; Leversedge, K; Smith, T; Snitzer, J | 1 |
| Egerer, G; Ehrhard, I; Goldschmidt, H; Haas, R; Sonntag, HG; Streich, N | 1 |
| Bingen, E; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G | 1 |
| Bhavsar, AR; Dessouki, A; Kashani, A; Yoshizumi, MO | 1 |
| English, BK; McCullers, JA; Novak, R | 1 |
| Breiman, RF; Cetron, M; Farley, MM; Fiore, AE; Harrison, LH; Jorgensen, JH; Kolczak, MS; Moroney, JF; Patterson, JE; Schuchat, A | 1 |
| Cottagnoud, M; Cottagnoud, P; Gerber, CM; Neftel, K; Täuber, MG | 1 |
| Isaacs, D | 1 |
| Berner, Y; Levi, S; Shahar, A | 1 |
| Cottagnoud, M; Cottagnoud, P; Gerber, CM; Neftel, KA; Täuber, MG | 1 |
| Knowles, SR; Louie, M; Oh, PI; Phillips, E; Simor, AE | 1 |
| Beauchamp, D; Bergeron, MG; Bergeron, Y; Simard, M; Wang, E | 1 |
| Kolpak, S; Mehler, PS | 1 |
| Al-Tawfiq, JA; Cushing, HE; Sarosi, GA | 1 |
| Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 1 |
| Feder, HM | 1 |
| Collins, J; Disney, A; Harris, DC; Ibels, LS; Murphy, BF; Rigby, R; Saltissi, D; Suranyi, M | 1 |
| Coldham, G; Grigsby, JH; Gruber, HE; Hanley, EN; Hoelscher, GL | 1 |
| Coplin, WM; Michael, DB; Murry, KR; Rebuck, JA; Rhoney, DH | 1 |
| Estes, L; Gosselin, VA; Hanssen, AD; Li, JT; Markus, PJ; Osmon, DR | 1 |
| DeFranco, PE; Goebel, J; Lee, B; Shook, LA | 1 |
| Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
| Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S; Torres, C | 1 |
| Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S | 1 |
| Gokal, R | 1 |
| Duch, JM; Yee, J | 1 |
| Gómez Navalón, LA; López Alonso, A; Salido Valle, JA | 1 |
| Lion, C; Lozniewski, A; Mory, F; Weber, M | 1 |
| Potasman, I; Yaniv, LG | 1 |
| Bergeret, M; Raymond, J | 1 |
| Kottilil, S; Menon, M; Papudesu, B; Yunis, N | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
| Cohen, C; Matthews, RP; Shah, SS | 1 |
| Araake, M; Hara, T; Miyata, A; Ogawa, H; Tani, M | 1 |
| Chen, J; Luo, W; Xiu, Q | 1 |
| Chow, KM; Leung, CB; Li, PK; Lui, SF; Szeto, CC; Wang, AY; Wong, TY; Wu, AK | 1 |
| Aubert, G; Carricajo, A; Vermesch, R | 1 |
| de Lalla, F | 1 |
| Chak, WL; Chan, YH; Chau, KF; Cheung, CY; Choi, KS; Leung, J; Leung, SH; Li, CS; Tsang, DN; Wong, KM | 1 |
| Servais, H; Tulkens, PM | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Ang, LP; Au Eong, KG; Lee, HM; Lim, AT; Yap, EY | 1 |
| Bertrand, X; Talon, D; Thouverez, M | 1 |
| Chavanet, P; Desbiolles, N; Lequeu, C; Neuwirth, C; Piroth, L; Portier, H | 1 |
| Danziger, LH; Itokazu, GS; Lesch, CA; Weinstein, RA | 1 |
| Bañón Arias, R; García López, M; Pinedo Sánchez, A | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Brod, RD; Galiani, D; Thomas, T | 1 |
| Arisi, A; Beghi, C; Cabassi, A; Campodonico, R; Fiaccadori, E; Gherli, T; Maggiore, U | 1 |
| Adler, Z; Bar-El, Y; Cohen, O; Finkelstein, R; Kertzman, V; Mashiah, T; Milo, S; Rabino, G | 1 |
| Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Chan, RC; Cheng, AF; Cheung, SW; Hui, M; Kwok, AK; Lam, DS; Pang, CP; Yip, CM | 1 |
| Andrieu, P; Archambaud, M; Bonnet, E; Chabanon, G; Chaminade, B; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Roche, C; Saivin, S; Samii, K; Virenque, C | 1 |
| Ericsson, C; Marcolini, J; Nguyen, M | 1 |
| Carmeli, Y; Eliopoulos, GM; Samore, MH | 1 |
| de André Júnior, LS; de Resende, MV; Schmidt, ML; Vieira, ML | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Ford-Jones, EL; Halperin, SA; Kellner, JD; Law, B; Le Saux, N; Lebel, MH; Moore, D; Scheifele, DW; Vaudry, W | 1 |
| Butt, T; Karamat, KA; Mahmood, A | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Dudley, MN; Griffith, DC; Harford, L; Lee, VJ; Williams, R | 1 |
| Bilker, WB; Fishman, NO; LaRosa, LA; Lautenbach, E; Marr, AM; Nachamkin, I | 1 |
| Asari, S; Horikawa, M; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M; Tsukamoto, H; Ueda, A | 1 |
| Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Addison, RM; Cole, EC; Criger, DA; Dulaney, PD; Gaber, DJ; Leese, KE; Newell, MS; Rubino, JR; Wilkins, J; Wineinger, T | 1 |
| Hermsen, ED; Hotchkiss, JR; Hovde, LB; Rotschafer, JC | 1 |
| Chong, Y; Hong, SG; Jang, SJ; Kim, M; Lee, HJ; Lee, K; Ryoo, N | 1 |
| Altinörs, N; Atalay, B; Caner, H; Ergin, F; Teksam, M | 1 |
| Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
| Barinov, SM; Hasegawa, M; Komlev, VS; Sudo, A; Uchida, A | 1 |
| Fynn-Thompson, F; Vander Salm, TJ | 1 |
| Bablekos, G; Charalabopoulos, A; Charalabopoulos, K; Karachalios, G; Karachaliou, I; Zoganas, L | 1 |
| Chambers, HF | 1 |
| Chenoweth, CE; DePestel, DD; Prager, RL | 1 |
| Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H | 1 |
| Greco, C; Lin, YC | 1 |
| Bento, M; Gjinovci, A; Lew, DP; Li, D; Schrenzel, J; Vaudaux, P | 1 |
| Rumbaugh, JA; Sinha, G; Spalding, C; Speedie, A; Venkatesan, A | 1 |
| Corbeel, L | 1 |
| Cabrera, D | 1 |
| Green, GR; Nadarajah, K; Naglak, M | 1 |
| Arango, JI; Bradshaw, P; Callander, NS; Freytes, CO; Ochoa-Bayona, JL; Patterson, J; Restrepo, A; Restrepo, MI; Schneider, DL | 1 |
| Fuda, C; Heilmayer, W; Hesek, D; Lee, M; Mobashery, S; Novak, R; Vakulenko, SB | 1 |
| Appelbaum, PC | 1 |
| Tenover, FC | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Leppänen, H; Metsärinne, KP; Nikoskelainen, J; Tertti, R | 1 |
| Koulenti, D; Rello, J | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Abdullah, WA; Ai, CL; Ariffin, H; Lee, CL | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Chen, SH; Wu, WY; Yang, YH; Yeh, HH | 1 |
| Helmann, JD; Salzberg, LI | 1 |
| Bugnon, D; Caillon, J; Ge, JY; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Das, A; Ge, Y; Talbot, GH; Thye, D | 1 |
| Main, C | 1 |
| Amsler, K; Heep, M; Noel, GJ; Pypstra, R; Solomkin, JS; Strauss, RS | 1 |
| Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A | 1 |
| Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM | 1 |
| Loffler, CA; Macdougall, C | 1 |
| Aujard, Y; Bingen, E; Boucherat, M; Cohen, R; d'Athis, P; de La Rocque, F; Levy, C; Varon, E | 1 |
| Bagchi, P; Bush, K; Ianus, J; Noel, GJ; Strauss, RS | 1 |
| Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
| Chrissoheris, MP; Kadakia, H; Libertin, C; Marieb, M | 1 |
| Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J | 1 |
| Jadoul, M; Labriola, L | 1 |
| Prokuski, L | 1 |
| Antignac, A; Chung, M; Kim, C; Tomasz, A | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Danielson, DR; Frigas, E; Kita, H; Markus, PJ; Narr, BJ; Olson, KE; Park, MA; Schroeder, DR; Volcheck, GW | 1 |
| Dehority, W; Leake, JA | 1 |
| Chung, GE; Kim, BH; Kim, EC; Kim, W; Kim, YJ; Lee, HS; Lee, JH; Myung, SJ; Yoon, JH | 1 |
| Heeney, MM; Hettmer, S | 1 |
| Almeida, SM; Berto, DB; Brandileone, MC; Dalla Costa, LM; Farah, SS; Gelain, M; Ramos, VH; Rossoni, AM | 1 |
| Decker, CF; Johnson, MD | 1 |
| Bao, J; Guo, F; Long, J; Song, L; Sun, H; Wang, S; Zhang, W | 1 |
| Chiquet, C; Cornut, PL | 1 |
| Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
| Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E | 1 |
| Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG | 1 |
| Bagchi, P; Kimko, H; Nandy, P; Noel, GJ; Samtani, MN; Strauss, RS; Xu, X | 1 |
| Hamamoto, H; Kurokawa, K; Lee, BL; Maki, H; Matsuo, M; Murakami, K; Nishida, S; Sekimizu, K; Yamane, N | 1 |
| Bannister, KM; Brown, FG; Hawley, CM; Johnson, DW; McDonald, SP; O'Shea, S; Rosman, JB; Wiggins, KJ | 1 |
| Chambers, D; Cranny, G; Eastwood, A; Elliott, RA; Hawkins, NS; Myers, L; Sculpher, MJ; Weatherly, HL | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 2 |
| Batard, E; Biek, D; Caillon, J; Ge, Y; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Eliopoulos, GM | 1 |
| Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P | 1 |
| Listernick, R | 1 |
| Bu-Coifiu Fanego, R; Dorta-Contreras, AJ; Lopez-Hernandez, I; O'Farril-Sanchez, M; Padilla-Docal, B | 1 |
| Diringer, MN; Moran, CJ; Ray, WZ; Zipfel, GJ | 1 |
| Johnson, L; Pawlak, J; Saravolatz, L | 1 |
| Chang, HH; Cheong, HS; Chung, DR; Heo, ST; Joung, MK; Jung, DS; Jung, SI; Ki, HK; Kim, SW; Kim, YS; Kwon, KT; Lee, H; Lee, JA; Lee, JS; Lee, SS; Moon, C; Moon, SY; Peck, KR; Rhee, JY; Ryu, SY; Shin, SY; Son, JS; Song, JH | 1 |
| Chahine, EB | 1 |
| Bhagan-Bruno, S; Fergus, IV; Lather, N | 1 |
| Amador, G; Batard, E; Biek, D; Caillon, J; Ge, Y; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
| Bacigalupo, A; Boni, L; Cappellano, P; Del Bono, V; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Prinapori, R; Raiola, AM; Van Lint, MT; Viscoli, C | 1 |
| Baculik, T; Corey, GR; Critchley, I; Das, AF; Friedland, HD; Talbot, GH; Thye, D; Wilcox, M; Witherell, GW | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Medico, CJ; Walsh, P | 1 |
| Baculik, T; Corey, GR; Friedland, D; Talbot, GH; Thye, D; Wilcox, MH | 2 |
| Corrado, ML | 1 |
| Daubner, B; Pichler, WJ; Wendland, T | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Farjoodi, P; Johnston, JC; Strike, SA | 1 |
| Mercuri, LG; Psutka, D | 1 |
| Matana Kaštelan, Z; Matana, A; Žagar, D | 1 |
| Clyburn, TA; Evans, RP; Moucha, CS; Prokuski, L | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Entenza, JM; Giddey, M; Majcherczyk, P; Moreillon, P; Veloso, TR; Vouillamoz, J | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Ambrose, PG; Bhavnani, SM; Blais, J; Hegde, SS; Obedencio, G; Okusanya, OO; Shaw, JP; Skinner, R | 1 |
| Benton, BM; Blais, J; Krause, KM; Lewis, SR | 1 |
| Abbanat, D; Amsler, K; Barron, AM; Fernandez, J; Flamm, RK; Hastings, J; He, W; Lynch, AS; Melton, JL; Queenan, AM; Shang, W | 1 |
| Citron, DM; Goldstein, EJ; Tyrrell, KL; Warren, YA | 1 |
| Drusano, GL | 1 |
| Biek, D; Eckburg, PB; Friedland, HD; Laudano, JB; Llorens, L; O'Neal, T; Rank, DR; Smith, A; Thye, D; Witherell, GW | 1 |
| Mullen, TD; Sharma, AK; Varma, AK | 1 |
| Dasgupta, A | 1 |
| Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM | 1 |
| Banerjee, R; Dubois, SG; Levy, ER; Swami, S; Wendt, R | 1 |
| Ahn, SH; Biek, D; Critchley, I; Fowler, VG; Lamlertthon, S; Llorens, L; Rude, T; Ruffin, F; Sharma-Kuinkel, BK; Tamarana, G; Tong, A; Tong, SY; Zhang, Y | 1 |
| Graviss, EA; Marconescu, P; Musher, DM | 1 |
| Barriere, SL; Churukian, A; Corey, GR; Kingsley, J; Li, YP; Potgieter, PD; Stryjewski, ME | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Boyer, MI; Osei, DA | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G; Tewhey, R; Werth, BJ | 1 |
| Giuliano, C; Johnson, LB; Kale-Pradhan, PB | 1 |
| Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A | 1 |
| Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Heidari, A; Jongsma, K; Joson, J | 1 |
| Cuthbertson, BH; Daneman, N; Fowler, RA; Sarwar, S | 1 |
| Murray, KP; Newton, KL; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Vidaillac, C; Werth, BJ | 1 |
| Bateman, BT; Bykov, K; Choudhry, NK; Fischer, MA; Franklin, JM; Gagne, JJ; Kulik, A; Liu, J; Polinski, JM; Rassen, JA; Schneeweiss, S | 1 |
| Kaatz, GW; Rybak, MJ; Steed, ME; Werth, BJ | 1 |
| Horbal, J; Hostoffer, R; Jhaveri, D; Marino, J; Sterbank, J; Tcheurekdijian, H; Tcheurekdjian, H | 1 |
| Buppajarntham, S; Junpaparp, P; Madueno, FV; Varadi, G | 1 |
| Rahiman, S; Tantry, BA | 1 |
| Flamm, RK; Jones, RN; Sader, HS | 1 |
| Beresford, E; Friedland, HD; Huang, X; Lodise, T | 1 |
| Beaume, M; Francois, P; Harrison, PF; Hernandez, D; Howden, BP; Schrenzel, J; Seemann, T; Stinear, TP | 1 |
| Belaieff, W; Bonvin, A; Francescato, M; Gamulin, A; Graf, V; Hoffmeyer, P; Schindler, M; Uçkay, I; Wyssa, B | 1 |
| Baek, JY; Chung, DR; Kang, CI; Kim, SH; Ko, J; Lee, NY; Park, SY; Peck, KR; Song, JH | 1 |
| Dalhoff, A; Schubert, S | 1 |
| Hung, YP; Ko, WC; Lee, CI; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wan, L; Wu, TC; Wu, YH | 1 |
| Finnegan, PM; Hand, S; Linneman, TW; McDonald, JR; Moenster, RP; Thomas, Z | 1 |
| Ak, O; Akbulut, A; Akcam, FZ; Akkoyunlu, Y; Alabay, S; Aydın, E; Balkan, II; Cetin, B; Cicek-Senturk, G; Dayan, S; Diktas, H; Elaldi, N; Erdem, H; Ersoy, Y; Ersoz, G; Erturk, A; Gozel, MG; Gundes, S; Gunduz, A; Guven, T; Hatipoglu, M; Inan, A; Inkaya, AC; Karabay, O; Karakas, A; Kaya, S; Kazak, E; Kose, S; Leblebicioglu, H; Nayman-Alpat, S; Oncul, O; Ozgunes, N; Öztoprak, N; Ozturk-Engin, D; Pehlivanoglu, F; Pekok, AU; Sagmak-Tartar, A; Savasci, U; Sener, A; Sengoz, G; Seyman, D; Sipahi, OR; Sirmatel, F; Tekin, R; Tosun, S; Tuncer-Ertem, G; Turhan, V; Ulcay, A; Ulu-Kilic, A; Vahaboglu, H; Yalci, A; Yasar, K; Yesilkaya, A; Yılmaz, H | 1 |
| Bhalodi, AA; Hagihara, M; Kuti, JL; Nicolau, DP | 1 |
| Crispell, EK; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; McDanel, JS; Riahi, F; Richter, SS; Satola, SW | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Arnold, W; Belden, K; Bicanic, G; Bini, S; Catani, F; Chen, J; Dahl, AW; Ghazavi, M; Godefroy, KM; Hansen, E; Holham, P; Hosseinzadeh, H; Kim, KI; Kirketerp-Møller, K; Lidgren, L; Lin, JH; Lonner, JH; Moore, CC; Papagelopoulos, P; Poultsides, L; Randall, RL; Roslund, B; Saleh, K; Salmon, JV; Schwarz, E; Silibovsky, R; Stuyck, J; Vogt, M; Yamada, K | 1 |
| Muscedere, J | 1 |
| Feng, X; He, L; He, Y; Li, C; Liu, H; Liu, X; Ruan, Y; Wu, X; Zhang, Y | 1 |
| Johnson, LB; Martin, H; Pawlak, J; Saravolatz, LD; Saravolatz, SN | 1 |
| Barber, KE; Ireland, CE; Rybak, MJ; Werth, BJ | 1 |
| Avutu, V; Cao, X; Flynn, PM; Gaur, AH; Hayden, RT; Howard, SC; Inaba, H; Marszal, LN; Pounds, SB; Pui, CH; Ribeiro, RC; Rubnitz, JE | 1 |
| Birch, A; Della Vecchia, BJ; Dupree, L; Gomes, DM; Jankowski, CA; Kraemer, DF; Smotherman, C | 1 |
| Benharash, P; Brindis, RG; Gregson, AL; Hsiue, PP; Injean, P; McKinnell, JA; Miller, LG; Shahian, DM; Shapiro, MF; Shemin, RJ; Vangala, S | 1 |
| Covens, L; Echahidi, F; François, K; Piérard, D; Pipeleers, L; Wybo, I; Yusuf, E | 1 |
| Aliota, MT; Ansari, IU; Boldon, KM; Knight, B; Pensinger, DA; Reniere, ML; Sauer, JD; Schaenzer, AJ; Striker, R; Vincent, WJ | 1 |
| Lebeaux, D; Touam, M | 1 |
| Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S | 1 |
| Barber, KE; Rybak, MJ; Sakoulas, G | 1 |
| Crémieux, AC; Gatin, L; Ghout, I; Laurent, F; Saleh-Mghir, A; Tasse, J | 1 |
| Holmes, NE; Howden, BP | 1 |
| Adelman, MH; Bader, J; Crane, JK; Jacobs, DM; Paladino, JA; Schentag, JJ; Shields, RK; Taylor, J; Wilton, GJ | 1 |
| Kuti, JL; MacVane, SH; Nicolau, DP; So, W | 1 |
| Stahlmann, R | 1 |
| Espedido, BA; Jensen, SO; van Hal, SJ | 1 |
| Eckmann, C | 1 |
| Braga-Mele, R; Chang, DF; Henderson, BA; Mamalis, N; Talley-Rostov, A; Vasavada, A | 1 |
| Bellew, SD; Kummer, T | 1 |
| Bright, A; DeClerck, B; Herbert, M; Jhun, P | 1 |
| Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M | 1 |
| Berti, AD; Hutson, PR; Rose, WE; Schulz, LT; Webb, AP | 1 |
| Routman, DM; Sabnis, A; Tam, JS | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Azzalis, LA; Bacci, MR; Bruniera, FR; Campos Junqueira, VB; da Luz Gonçalves Pedreira, M; Feder, D; Ferreira, FM; Fonseca, FL; Saviolli, LR; Sorgini Peterlini, MA | 1 |
| Mahfood Haddad, T; Sundaragiri, PR; Vallabhajosyula, S; Vivekanandan, R | 1 |
| Gomes, DM; LaPlante, KL; Ward, KE | 1 |
| Manno, M; Wing, R | 1 |
| Barber, KE; Boles, BR; Ireland, CE; Rose, WE; Rybak, MJ; Smith, JR | 1 |
| Graber, CJ; Labreche, MJ; Nguyen, HM | 1 |
| Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
| Boyd, AS; Di Pentima, MC; Willis, ZI | 1 |
| Esterbrooks, DJ; Haddad, TM; Sundaragiri, PR; Vallabhajosyula, S | 1 |
| Gelijns, AC; Koll, BS; Mazumdar, M; Meyer, J; Moskowitz, A; Poeran, J; Rasul, R; Sacks, HS; Wallach, FR | 1 |
| Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Bao, Y; Mo, Y; Qi, S; Qiu, B; Zeng, H; Zhang, N | 1 |
| Cohen, H; Peyko, V; Smalley, S | 1 |
| Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN | 1 |
| Azar, MM; Malinis, MF | 1 |
| Jones, RN; Mendes, RE; Schuchert, JE | 1 |
| Blumer, JL; Bradley, JS; Cannavino, C; Friedland, HD; Ghonghadze, T; Jandourek, A; O'Neal, T | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Kaul, M; LaVoie, EJ; Mark, L; Parhi, AK; Pilch, DS | 1 |
| Deresinski, S; Holubar, M; Meng, L | 1 |
| Cole, NC; Greenwood-Quaintance, KE; Harper, LW; Ihde, SM; Kohner, PC; Mushtaq, A; Patel, R; Strand, GJ; Virk, A | 1 |
| Abdulsalam, A; Kamaldeen, B; Roaa, Z; Shahid, G; Tariq, AF | 1 |
| Blomquist, PH; Huang, JM; Pansick, AD | 1 |
| Fang, H; Fröding, I; Gian, B; Hæggman, S; Nord, CE; Tollström, UB; Ullberg, M | 1 |
| Athans, V; Davis, SL; Kenney, RM; Wong, J | 1 |
| Candel, FJ; Chiarella, F; García, AB; López, L; Viñuela-Prieto, JM | 1 |
| Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y | 1 |
| Casapao, AM; Claeys, KC; Davis, SL; Klinker, KP; Lagnf, AM; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Burgess, DR; Burgess, DS; Cox, JN; Martin, CA; Rutter, WC | 1 |
| Evans, R; Hussain, T; Karino, S; Kaye, KS; Koons, J; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Perry, W; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Altshuler, J; Fedorenko, M; Gritsenko, D; Ruhe, JJ | 1 |
| Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
| Fernandez, J; Nanjappa, S; Pabbathi, S; Srikumar, T | 1 |
| Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y | 1 |
| Arshad, S; Hartman, P; Huang, V; Moreno, D; Perri, MB; Zervos, MJ | 1 |
| Chen, CC; Chuang, YC; Lai, CC; Tang, HJ | 1 |
| Hoff, JS; Kellogg, SL; Kristich, CJ; Little, JL | 1 |
| Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G | 1 |
| Boka, K; Cortes, J; Lee, Y; Sagar, AS; Sandhu, U | 1 |
| Heisel, RW; Lim, SH; Mascara, GP; Oleksiuk, LM; Sutton, RR; Weber, DR; Winger, DG | 1 |
| LeCleir, LK; Pettit, RS | 1 |
| Hincapie Castillo, J; Jeon, N; Klinker, KP; Staley, B; Winterstein, AG | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Maxson, T; Minogue, TD; Taylor-Howell, CL | 1 |
| Beckman, TJ; Eichenberg, SE; Go, SA; Phuoc, VH; Temesgen, Z | 1 |
| Bloom, A; DeYoung, H; Tamayo, S | 1 |
| Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R | 1 |
| Rybak, MJ; Tran, N | 1 |
| Awosile, B; German, G; Heider, LC; McClure, JT; Rodriguez-Lecompte, JC; Saab, ME | 1 |
| Adler, A; Carmeli, Y; Cohen, D; Miller-Roll, T; Na'amnih, W | 1 |
| Jayaraman, R; Kumar, JL; Neeravi, A; Ralph, R; Shanmugasundaram, D; Thomas, K; Varghese, R; Veeraraghavan, B | 1 |
| Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
| Olarte, L | 1 |
| Cuénod, A; Egli, A; Hinic, V; Khanna, N; Kuehl, R; Morgenstern, M; Wüthrich, D | 1 |
| Alemkere, G; Engidawork, E; Tenna, A | 1 |
| Baggs, J; Guh, A; Hatfield, KM; Jernigan, JA; Kazakova, SV; McDonald, LC; Reddy, SC; Yi, SH | 1 |
| Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ | 1 |
| Gil Romero, Y; Gómez-Garcés, JL | 1 |
| Arts, SH; Boogaarts, HD; van Lindert, EJ | 1 |
| Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
| Claeys, KC; Davis, SL; Delaportes, DJ; Estrada, SJ; Huang, V; Jorgensen, SCJ; Kaye, KS; Klinker, KP; Lagnf, AM; Rybak, MJ; Trinh, TD; Zasowski, EJ | 1 |
| Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF | 1 |
| Awad, AR; Elawady, BA; ElFeky, DS; Elshobaky, MA | 1 |
| Karahan, ZC; Ozmen Capin, BB; Tekeli, A | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Chang, SC; Chen, PY; Chen, YC; Chuang, YC; Sheng, WH; Wang, JT | 1 |
| Cuba, GT; da Costa, TM; Dos Santos, KRN; Kiffer, CRV; Morgado, PGM; Nicolau, DP; Nouér, SA | 1 |
| Arda, B; Aydemir, S; Bolat, E; Mermer, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Turhan, T; Ulusoy, S; Yamazhan, T | 1 |
| Adeli, M; Mauger, TF | 1 |
| Arif, S; Bishawi, M; Maskarinec, SA; Milano, C; Miller, RA; Mourad, A | 1 |
| Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
| Benner, K; Branstetter, J; Crowder, C; Searcy, H; Troxler, B; Yarbrough, A | 1 |
| Herc, ES; Hutton, MA; Perri, MB; Sundaram, A; Zervos, MJ | 1 |
| Engelhardt, M; Gonzalez-Rojas, Y; Gumenchuk, I; Hamed, KA; Ionescu, D; Jones, ME; Keech, R; Kim, C; Ninov, B; Overcash, JS; Saulay, M; Simeonov, S; Smart, JI; Waters, M | 1 |
| Alegria, W; Deresinski, S; Holubar, M; Meng, L | 1 |
| Algorri, M; Wong-Beringer, A | 1 |
| Cowart, MC; Ferguson, CL; Jordan-Villegas, A; Laham, F | 1 |
| Berry, DE; Cribbs, BE; Hendrick, A; Hubbard, GB; Jain, N; Meyer, BI; O'Keefe, G; Patel, PS; Rao, P; Shantha, JG; Yan, J; Yeh, S | 1 |
| Bosheva, M; Gujabidze, R; Hamed, KA; Károly, É; Nemeth, A; Saulay, M; Smart, JI | 1 |
| Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW | 1 |
| Atilla, B; Çağlar, Ö; Çil, A; Kaymakoğlu, M; Sarıcaoğlu, F; Tokgözoğlu, M | 1 |
| Dahdouh, E; Díaz-Pollán, B; Falces-Romero, I; Gómez-Gil, R; Mingorance, J | 1 |
| Brateanu, A; Imrey, PB; Le, P; Navaneethan, SD; Pallotta, AM; Patel, P; Rastogi, R; Rothberg, MB; Yu, PC | 1 |
| Esquivel, MD; Finklea, JD; Monogue, ML; Sanders, JM; Smith, GS | 1 |
| Andrick, B; Leri, F; Okubo, L; Rampulla, R | 1 |
| Abate, G; Frisby, J; Wang, G | 1 |
| Aouam, K; Ben Fadhel, N; Ben Fredj, N; Ben Romdhane, H; Chaabane, A; Chadli, Z; Mansour, K | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Sheng, WH; Tsai, CE; Wang, JT; Yang, CJ | 1 |
| Alt, V; Bärtl, S; Hitzenbichler, F; Lang, S; Rupp, M; Walter, N | 1 |
| Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
| Blaine, BE; Kufel, WD; Mahapatra, R; Paolino, KM; Parsels, KA; Steele, JM; Thomas, SJ | 1 |
| Ham, CH; Hofstetter, CP; Kim, JH; Kwon, WK; Moon, HJ; Park, YK | 1 |
| Diao, S; Liu, Y; Lu, T; Shi, Z; Waheed, MZ; Wang, D; Wang, H; Xu, X; Zhang, H; Zhou, J | 1 |
| Fromow-Guerra, J; Monroy-Esquivel, L; Ortiz-Guevara, R; Quiroz-Mercado, H; Velez-Montoya, R | 1 |
| Chen, W; Clarke, HD; Spangehl, MJ; Young, SW | 1 |
93 review(s) available for cephalosporin c and vancomycin
| Article | Year |
|---|---|
Selection and use of antibacterial drugs.
Topics: Aminoglycosides; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Interactions; Humans; Lincomycin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Penicillins; Polymyxins; Spectinomycin; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
[Use of antibiotics during pregnancy (review of the literature)].
Topics: Abnormalities, Drug-Induced; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Female; Fetus; Humans; Maternal-Fetal Exchange; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Ristocetin; Tetracyclines; Vancomycin | 1975 |
Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Clindamycin; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Infant; Kidney Diseases; Lincomycin; Nalidixic Acid; Nitrofurans; Oxolinic Acid; Penicillin Resistance; Penicillins; Polymyxins; Rifampin; Sulfamethoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1978 |
Antimicrobial therapy.
Topics: Adult; Aminoglycosides; Anti-Infective Agents; Anti-Infective Agents, Urinary; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Humans; Imidazoles; Infant, Newborn; Lincomycin; Penicillins; Polymyxins; Rifamycins; Sulfonamides; Tetracyclines; Vancomycin | 1979 |
Bacterial meningitis--1978.
Topics: Adult; Cephalosporins; Cerebrospinal Fluid; Child; Child, Preschool; Chloramphenicol; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Penicillins; Prognosis; United States; Vancomycin | 1978 |
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Mycoses; Nalidixic Acid; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim; Urinary Tract Infections; Vancomycin | 1979 |
An overview of antimicrobial therapy.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Humans; Macrolides; Microbial Sensitivity Tests; Monobactams; Penicillins; Sulfonamides; Vancomycin | 1992 |
[Enterococci: acquired antibiotic resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Urinary Tract Infections; Vancomycin | 1992 |
Antibiotic choices in surgical intensive care unit patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Carbapenems; Cephalosporins; Critical Care; Drug Resistance, Microbial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Mycoses; Penicillins; Pneumonia; Surgical Wound Infection; Vancomycin | 1991 |
Antibiotic-impregnated beads. Part II: Factors in antibiotic selection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Infections; Methylmethacrylates; Osteomyelitis; Penicillins; Vancomycin | 1991 |
Current concepts in prevention of prosthetic valve endocarditis.
Topics: Animals; Cephalosporins; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Premedication; Sepsis; Vancomycin | 1990 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Bacterial meningitis. Rational selection and use of antibacterial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Therapy, Combination; Humans; Kinetics; Meningitis; Penicillins; Sulfamethoxazole; Sulfonamides; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Current problems of chemotherapy of infections with coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Drug Therapy, Combination; Humans; Infant, Newborn; Methicillin; Penicillin Resistance; Plasmids; Prostheses and Implants; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1986 |
Treatment of bacterial infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Humans; Infant, Newborn; Metronidazole; Penicillins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
Antibiotic monitoring in body fluids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Biological Assay; Body Fluids; Cephalosporins; Chloramphenicol; Chromatography, Gas; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Humans; Immunoassay; Monitoring, Physiologic; Penicillins; Rifampin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thiamphenicol; Vancomycin | 1985 |
Staphylococcal infections--treatment and control.
Topics: Carrier State; Cephalosporins; Cross Infection; Hospitalization; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lysostaphin; Osteomyelitis; Penicillins; Staphylococcal Infections; Staphylococcal Toxoid; Staphylococcal Vaccines; Staphylococcus; Staphylococcus Phages; Vancomycin; Wound Infection | 1968 |
Antimicrobial agents in the treatment of obstetric and gynecologic infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Female; Genital Diseases, Female; Genitalia, Female; Humans; Idoxuridine; Infections; Lactobacillus; Metronidazole; Penicillins; Placenta; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Pyrimethamine; Spectinomycin; Streptococcus; Sulfonamides; Tetracycline; Vagina; Vancomycin | 1974 |
The mechanism of action of some antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Bacitracin; Bacteria; Cell Membrane; Cell Wall; Cephalosporins; Chloramphenicol; Cycloserine; Dactinomycin; Edetic Acid; Lysostaphin; Metals; Mitomycins; Mucoproteins; Muramidase; Nalidixic Acid; Novobiocin; Nucleic Acids; Penicillins; Peptide Biosynthesis; Phenols; Polymyxins; Puromycin; Quaternary Ammonium Compounds; Ristocetin; Streptomycin; Tetracycline; Vancomycin | 1969 |
Allergic penicillin reactions.
Topics: Adrenocorticotropic Hormone; Cephalosporins; Chemical Phenomena; Chemistry; Drug Hypersensitivity; Endocarditis, Bacterial; Epinephrine; Humans; Penicillins; Skin Tests; Vancomycin | 1971 |
[Antibiotic therapy: general principles, principle antibiotics, their indications and side effects].
Topics: Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Infections; Lincomycin; Penicillins; Polymyxins; Rifampin; Tetracycline; Vancomycin | 1971 |
Antibiotics and the kidney.
Topics: Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Gentamicins; Humans; Kanamycin; Kidney; Kidney Diseases; Neomycin; Penicillins; Polymyxins; Regional Blood Flow; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1973 |
Adverse effects of antibiotics.
Topics: Aminoglycosides; Ampicillin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Carbenicillin; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Dermatitis; Drug Hypersensitivity; Gentamicins; Humans; Kanamycin; Kidney Diseases; Lincomycin; Neomycin; Penicillins; Polymyxins; Streptomycin; Tetracycline; Vancomycin | 1972 |
The practical management of ocular infections. I. Bacterial infections.
Topics: Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cephalosporins; Erythromycin; Eye Diseases; Gentamicins; Humans; Lincomycin; Methicillin; Nafcillin; Penicillin G; Penicillins; Tetracycline; Vancomycin | 1972 |
[Antibiotics. Clinical use and adverse effects].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Erythromycin; Humans; Penicillin Resistance; Penicillins; Rifampin; Ristocetin; Tetracycline; Vancomycin | 1972 |
Modern management of severe staphylococcal disease.
Topics: Anti-Bacterial Agents; Carbon Dioxide; Carbon Isotopes; Cephalosporins; Cross Infection; Europe; Hospitals, Teaching; Humans; Israel; Penicillin Resistance; Penicillins; Protein Binding; Staphylococcal Infections; Staphylococcus; Time Factors; United States; Vancomycin | 1973 |
[Actual problems in clinical chemotherapy].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cephalosporins; Endocarditis, Bacterial; Enteritis; Gentamicins; Humans; Infections; Lincomycin; Meningitis; Penicillins; Rifampin; Sepsis; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Urinary Tract Infections; Vancomycin | 1967 |
Composition of bacterial cell walls in relation to antibiotic action.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Bacteria; Carbamates; Cell Wall; Cephalosporins; Cycloserine; Escherichia coli; Glucosamine; Lipid Metabolism; Lysostaphin; Nucleotides; Penicillins; Peptides; Ristocetin; Serine; Staphylococcus; Vancomycin | 1969 |
Composition of bacterial cell walls in relation to antibiotic action.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Bacteria; Cell Wall; Cephalosporins; Cycloserine; Lipid Metabolism; Lysostaphin; Penicillins; Peptide Biosynthesis; Ristocetin; Vancomycin | 1969 |
[Molecular mechanism of inhibition of biosynthesis of peptidoglycan of bacterial cell walls by antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacteria; Cell Wall; Cephalosporins; Chemistry Techniques, Analytical; Cycloserine; Depression, Chemical; Escherichia coli; Methicillin; Micrococcus; Penicillin G; Penicillins; Peptide Biosynthesis; Peptides; Polysaccharides; Polysaccharides, Bacterial; Ristocetin; Staphylococcus; Vancomycin | 1970 |
Clinical implications of the mechanism of action of antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacitracin; Cell Membrane; Cell Wall; Cephalosporins; Chloramphenicol; Cycloserine; Drug Synergism; Erythromycin; Humans; Nalidixic Acid; Novobiocin; Nucleic Acids; Penicillin Resistance; Penicillins; Protein Biosynthesis; Rifampin; Ristocetin; Sulfonamides; Tetracycline; Vancomycin | 1970 |
Antimicrobial agents and the central nervous system.
Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Cephamycins; Chloramphenicol; Erythromycin; Humans; Infections; Lincomycin; Meningitis; Metronidazole; Penicillins; Polymyxins; Rifampin; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1980 |
The neurotoxicity of antibacterial agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Colistin; Cranial Nerve Diseases; Dapsone; Erythromycin; Ethambutol; Humans; Lincomycin; Metronidazole; Nervous System Diseases; Neuromuscular Junction; Penicillins; Peripheral Nervous System Diseases; Polymyxin B; Sulfonamides; Tetracyclines; Vancomycin | 1984 |
Antibiotics in surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Clindamycin; Erythromycin; Humans; Metronidazole; Penicillins; Preoperative Care; Surgical Wound Infection; Tetracyclines; Vancomycin | 1983 |
The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Kinetics; Microbial Sensitivity Tests; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1984 |
Antimicrobial therapy in musculoskeletal surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Arthritis, Infectious; Bone Diseases; Cephalosporins; Clindamycin; Humans; Muscular Diseases; Osteomyelitis; Penicillins; Vancomycin; Wound Infection | 1984 |
Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Cimetidine; Drug Combinations; Half-Life; Humans; Kinetics; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Pharmaceutical Preparations; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Aspects on antibacterial treatment of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Cephalosporins; Chloramphenicol; Clindamycin; Humans; Metronidazole; Penicillins; Tetracyclines; Tinidazole; Vancomycin | 1982 |
Antimicrobial agents in pulmonary infections.
Topics: Aminoglycosides; Amphotericin B; Anti-Infective Agents; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Miconazole; Penicillins; Respiratory Tract Infections; Tetracycline; Vancomycin | 1980 |
Management of infective endocarditis.
Topics: Anticoagulants; Blood Bactericidal Activity; Cephalosporins; Endocarditis, Bacterial; Heart Valve Prosthesis; Hemodynamics; Humans; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus; Streptococcus; Time Factors; Vancomycin | 1981 |
Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Topics: Australia; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bone Cements; Bone Diseases; Cephalosporins; Drug Delivery Systems; Humans; Methylmethacrylates; Microspheres; Osteomyelitis; Penicillins; Soft Tissue Infections; Vancomycin | 1995 |
[How to diagnose and treat peritoneal infections in patients with terminal chronic renal insufficiency treated by peritoneal dialysis].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Peritoneal Diseases; Vancomycin | 1995 |
Therapy of penicillin-resistant pneumococcal meningitis.
Topics: Bacterial Vaccines; Cephalosporins; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Vancomycin | 1995 |
[Antibiotic prophylaxis in heart surgery].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cardiac Surgical Procedures; Cephalosporins; Heart Transplantation; Humans; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 1994 |
Clinical pharmacokinetics during continuous haemofiltration.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin | 1994 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Vancomycin | 1995 |
[Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
Emergence of drug resistance. Impact on bacterial meningitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Humans; Meningitis, Bacterial; Neisseria meningitidis; Penicillins; Rifampin; Streptococcus pneumoniae; Vancomycin | 1999 |
Pyomyositis in the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Drainage; Follow-Up Studies; HIV Infections; Humans; Leukocytosis; Male; Muscle, Skeletal; Muscular Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Peritoneal dialysis. Prevention and control of infection.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Equipment Contamination; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome; Vancomycin | 2000 |
Iatrogenic meningitis: an increasing role for resistant viridans streptococci? Case report and review of the last 20 years.
Topics: Anesthesia, Spinal; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Iatrogenic Disease; Male; Meningitis, Bacterial; Middle Aged; Spinal Puncture; Streptococcal Infections; Streptococcus; Vancomycin | 2000 |
Group C streptococcal meningitis: case report and review of the literature.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Meningitis, Bacterial; Streptococcal Infections; Streptococcus equi; Vancomycin | 2001 |
Endogenous Klebsiella endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Endophthalmitis; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome; Vancomycin; Visual Acuity | 2000 |
[Risk factors and prevention of the acquisition and transmission of glycopeptide resistant enterococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Risk Factors; Vancomycin | 2001 |
Gentamicin and other antibiotic toxicitiy.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Eye; Eye Diseases; Gentamicins; Humans; Vancomycin | 2001 |
Methods for reduction of sternal wound infection.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Humans; Hyperglycemia; Risk Reduction Behavior; Staphylococcal Infections; Sternum; Surgical Wound Infection; Suture Techniques; Vancomycin | 2004 |
[Antibiotics and overweight].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin | 2005 |
MRSA--the tip of the iceberg.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Mechanisms of antimicrobial resistance in bacteria.
Topics: Adult; Arteriovenous Shunt, Surgical; beta-Lactamases; Cell Wall; Cephalosporins; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Humans; Isoelectric Focusing; Methicillin Resistance; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
Pacemaker pocket infection due to Mycobacterium goodii: case report and review of the literature.
Topics: Aged, 80 and over; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Mycobacterium Infections; Pacemaker, Artificial; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Prophylactic antibiotics in orthopaedic surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Drug Hypersensitivity; History, 19th Century; History, 20th Century; Humans; Methicillin Resistance; Orthopedic Procedures; Orthopedics; Surgical Wound Infection; Vancomycin | 2008 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Early endovascular coiling of posterior communicating artery saccular aneurysm in the setting of Staphylococcus bacteremia: case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Embolization, Therapeutic; Female; Humans; Staphylococcal Infections; Subarachnoid Hemorrhage; Vancomycin | 2010 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Advances in antibiotic measurement.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Chloramphenicol; Chromatography; Humans; Immunoassay; Macrolides; Penicillins; Quinolones; Sulfonamides; Vancomycin | 2012 |
Preoperative antibiotic prophylaxis in the penicillin-allergic patient.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clindamycin; Contraindications; Decision Making; Drug Hypersensitivity; Humans; Penicillins; Preoperative Care; Surgical Wound Infection; Vancomycin | 2012 |
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clinical Trials as Topic; Cross Infection; Decontamination; Digestive System; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacteriaceae; Europe; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Neomycin; Nystatin; Odds Ratio; Oropharynx; Polymyxins; Prevalence; Primary Prevention; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; South Africa; Tobramycin; United States; Vancomycin | 2013 |
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin | 2014 |
What's new in the treatment of serious MRSA infection?
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2014 |
[Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Evidence-Based Medicine; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin | 2014 |
Intracameral antibiotics: Safety, efficacy, and preparation.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pharmaceutical Preparations; Treatment Outcome; Vancomycin | 2014 |
The use of vancomycin with its therapeutic and adverse effects: a review.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neutropenia; Vancomycin | 2015 |
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Linezolid; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Staphylococcal Infections; Streptococcus pneumoniae; Vancomycin | 2015 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cerebrospinal Fluid Shunts; Drug Administration Routes; Gentamicins; Humans; Penicillins; Prosthesis-Related Infections; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2019 |
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult | 2020 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
ALTERNATIVE INTRAVITREAL ANTIBIOTICS: A Systematic Review for Consideration in Recalcitrant or Resistant Endophthalmitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Vancomycin | 2023 |
40 trial(s) available for cephalosporin c and vancomycin
| Article | Year |
|---|---|
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1983 |
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrol
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1995 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enteritis; Female; Humans; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcus aureus; Treatment Outcome; Vancomycin | 1997 |
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Ecosystem; Enterococcus; Feces; Female; Genotype; Gram-Positive Cocci; Humans; Intestinal Mucosa; Intestines; Male; Middle Aged; Time Factors; Vancomycin | 1997 |
Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Female; Finland; Humans; Male; Middle Aged; Surgery Department, Hospital; Surgical Wound Infection; Vancomycin | 1998 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Injections, Intraperitoneal; Peritoneal Dialysis; Peritonitis; Prospective Studies; Teicoplanin; Vancomycin | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
[Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination].
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Postoperative Complications; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 1999 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Cephalosporins; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Vancomycin | 1999 |
Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Drug Hypersensitivity; Drug Utilization; Female; Humans; Male; Middle Aged; Orthopedic Procedures; Penicillins; Practice Patterns, Physicians'; Preoperative Care; Referral and Consultation; Skin Tests; Total Quality Management; Vancomycin | 2000 |
Preoperative vancomycin prophylaxis for newly placed peritoneal dialysis catheters prevents postoperative peritonitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Prospective Studies; Vancomycin | 2000 |
Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Prospective Studies; Urinary Catheterization; Vancomycin | 2000 |
Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Treatment Outcome; Vancomycin | 2001 |
Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefazolin; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Prevalence; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2002 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
Topics: Adult; Aged; Bacteremia; Cefpirome; Cephalosporins; Critical Care; Drug Therapy, Combination; Female; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Cefepime monotherapy for treatment of febrile neutropenia in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Malaysia; Male; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 2006 |
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Skin Diseases, Infectious; Streptococcus agalactiae; Treatment Outcome; Vancomycin | 2007 |
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Topics: Aged; Ceftazidime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillin G; Perioperative Care; Preoperative Care; Skin Tests; Vancomycin | 2008 |
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2010 |
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2012 |
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Glycopeptides; Humans; Injections, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin; Skin Diseases, Bacterial; Staphylococcal Infections; Vancomycin | 2012 |
Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infection Control; Length of Stay; Leukemia, Myeloid, Acute; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin | 2014 |
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2016 |
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult | 2016 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2021 |
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2021 |
405 other study(ies) available for cephalosporin c and vancomycin
| Article | Year |
|---|---|
Antibiotic managment in renal failure.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Humans; Kidney Failure, Chronic; Penicillins; Polymyxins; Tetracyclines; Urologic Diseases; Vancomycin | 1976 |
Physical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions - part III.
Topics: Amikacin; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Incompatibility; Drug Stability; Erythromycin; Injections, Intravenous; Kanamycin; Lincomycin; Novobiocin; Penicillins; Polymyxins; Solutions; Tetracyclines; Time Factors; Vancomycin | 1976 |
Antibiotic-tolerant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Penicillin Resistance; Penicillins; Staphylococcus aureus; Time Factors; Vancomycin | 1978 |
Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
Topics: Cefazolin; Cephalosporins; Cephalothin; Dose-Response Relationship, Drug; Drug Synergism; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus; Vancomycin | 1979 |
Prophylactic antibiotics in prosthetic implant surgery.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephradine; Humans; Prostheses and Implants; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 1979 |
In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.
Topics: Cephalosporins; Coagulase; Gentamicins; Methicillin; Vancomycin | 1978 |
Persistent bacteremia in staphylococcal endocarditis.
Topics: Adult; Aged; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Vancomycin | 1978 |
Blood level determinations of antimicrobial drugs. Some clinical considerations.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Kidney Failure, Chronic; Penicillins; Vancomycin | 1978 |
Treatment of bacterial endocarditis 1976.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Endocarditis, Bacterial; Enterococcus faecalis; Fusidic Acid; Humans; Lincomycin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Streptococcus sanguis; Vancomycin | 1976 |
Antimicrobial therapy of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Bacteria; Humans; Lincomycin; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Thiamphenicol; Vancomycin | 1975 |
In vitro activity of cefpirome (HR 810) against enterococci and staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterococcus faecalis; Microbial Sensitivity Tests; Species Specificity; Staphylococcus; Vancomycin | 1992 |
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-1992. A 55-year-old man with recurrent pericardial and pleural effusions after aortic-valve replacement.
Topics: Aortic Valve; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Pericarditis; Pleural Effusion; Postoperative Complications; Propionibacterium acnes; Suppuration; Vancomycin | 1992 |
The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Topics: Cefoperazone; Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1992 |
Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.
Topics: Absorption; Aminoglycosides; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Drug Administration Routes; Humans; Injections, Intraperitoneal; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Vancomycin | 1992 |
[Methicillin-cephem-resistant Staphylococcus aureus (MRSA) mediastinitis following open heart surgery].
Topics: Cephalosporins; Child; Drainage; Drug Resistance, Microbial; Heart Septal Defects, Atrial; Humans; Male; Mediastinitis; Methicillin Resistance; Osteomyelitis; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
In vitro activity of flomoxef and cefazolin in combination with vancomycin.
Topics: Cefazolin; Cephalosporins; Drug Therapy, Combination; Microbial Sensitivity Tests; Vancomycin | 1991 |
Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Humans; Kidney; Neoplasms; Retrospective Studies; Vancomycin | 1991 |
[Biological types and drug-sensitivities of multiple strains of freshly isolated methicillin-resistant Staphylococcus aureus].
Topics: Cefamandole; Cephalosporins; Cephalothin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1991 |
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Erythromycin; Gram-Negative Bacteria; Mice; Netilmicin; Pseudomonas aeruginosa; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
[In vitro antibiotic susceptibility of staphylococci].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Sulbactam; Vancomycin | 1989 |
Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.
Topics: Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Humans; Infant; Injections, Intravenous; Vancomycin | 1989 |
Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Methicillin; Penicillin Resistance; Peptides; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Erythromycin; Humans; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Streptomycin; Vancomycin | 1986 |
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
Topics: Ampicillin; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Enterococcus faecalis; Glycopeptides; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Streptococcus; Teicoplanin; Vancomycin | 1985 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
Topics: Cefamandole; Cefazolin; Cephalosporins; Cephalothin; Coagulase; Humans; Microbial Sensitivity Tests; Nafcillin; Penicillin Resistance; Regression Analysis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Vancomycin | 1986 |
Staphylococcal infections in hospital.
Topics: Catheters, Indwelling; Cephalosporins; Cross Infection; Gentamicins; Humans; Methicillin; Penicillin Resistance; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; United Kingdom; Vancomycin | 1986 |
Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Culture Media; Drug Resistance, Microbial; Fusidic Acid; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rifampin; Sodium Chloride; Staphylococcus; Temperature; Vancomycin | 1987 |
Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cost Control; Costs and Cost Analysis; Drug Utilization; Formularies, Hospital as Topic; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Missouri; Pharmacy Service, Hospital; Regression Analysis; Retrospective Studies; Sepsis; Vancomycin | 1987 |
Choosing antimicrobials. Factors to consider, available agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Clindamycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Kidney Failure, Chronic; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Tissue Distribution; Vancomycin | 1985 |
The newer antimicrobials.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Bacteria; Cephalosporins; Chloramphenicol; Deoxyuridine; Drug Combinations; Erythromycin; Humans; Metronidazole; Penicillins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Viruses | 1985 |
Antibiotic-associated pseudomembranous colitis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin | 1985 |
Infections in heroin addicts.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Kanamycin; Morphine Dependence; Sepsis; Staphylococcal Infections; Vancomycin | 1967 |
Growing clinical significance of methcillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1968 |
Methicillin-resistant staphylococci.
Topics: Ampicillin; Cephalosporins; Cloxacillin; Humans; Methicillin; Penicillin G; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Vancomycin | 1968 |
Clinical useful antimicrobial agents. General considerations concerning chloramphenicol, erythromycin and allied drugs, the polymyxins, bacitracin, vancomycin, ristocetin, cycloserine, the cephalosporins, the chemotherapeutic drugs and the antimycotic dru
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Cephalosporins; Chloramphenicol; Erythromycin; Humans; Lincomycin; Polymyxins; Sulfonamides; Vancomycin | 1967 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
Antibiotic sensitivity testing. Report of an international collaborative study.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacitracin; Bacteria; Bacteriological Techniques; Blood; Carbon Dioxide; Cephalosporins; Chloramphenicol; Colistin; Culture Media; Erythromycin; Hydrogen-Ion Concentration; In Vitro Techniques; International Cooperation; Kanamycin; Lincomycin; Methods; Microbial Sensitivity Tests; Neomycin; Novobiocin; Oleandomycin; Paper; Penicillinase; Penicillins; Polymyxins; Sheep; Streptomycin; Tetracycline; Vancomycin; World Health Organization | 1971 |
Recurrent osteomyelitis. Report of four cases culturing L-form variants of Staphylococci.
Topics: Adolescent; Adult; Cephalosporins; Chloramphenicol; Chronic Disease; Culture Media; Enterococcus faecalis; Erythromycin; Female; Femoral Fractures; Femur Head; Humans; Hypertonic Solutions; Kanamycin; L Forms; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Osteomyelitis; Penicillins; Polymyxins; Proteus; Radiography; Staphylococcal Infections; Staphylococcus; Tetracycline; Vancomycin | 1971 |
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis.
Topics: Adult; Aged; Ampicillin; Cephalosporins; Child; Chloramphenicol; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Gastrointestinal Diseases; Gentamicins; Humans; Kanamycin; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxacillin; Penicillin G; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Urologic Diseases; Vancomycin | 1974 |
The synthesis of peptidoglycan in an autolysin-deficient mutant of Bacillus licheniformis N.C.T.C. 6346 and the effect of beta-lactam antibiotics, bacitracin and vancomycin.
Topics: Alanine; Anti-Bacterial Agents; Bacillus; Bacitracin; Carboxypeptidases; Cell Membrane; Cell Wall; Cephalosporins; Chromatography, Paper; Electrophoresis, Paper; Hydroxylamines; Mutation; Penicillins; Peptidoglycan; Temperature; Vancomycin | 1974 |
Endocarditis due to Micrococci and Staphylococcus epidermidis.
Topics: Adolescent; Adult; Aged; Cardiac Catheterization; Cardiac Surgical Procedures; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Dental Prophylaxis; Endocarditis, Bacterial; Erythromycin; Humans; Lincomycin; Micrococcus; Middle Aged; Penicillin Resistance; Penicillins; Postoperative Complications; Staphylococcal Infections; Staphylococcus; Streptomycin; Urologic Diseases; Vancomycin | 1973 |
Antibiotics for treatment of infections caused by gram-positive cocci.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Chloramphenicol; Clindamycin; Cloxacillin; Drug Hypersensitivity; Erythromycin; Humans; Lincomycin; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Tetracycline; Vancomycin | 1974 |
Drugs for staphylococcal infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Clindamycin; Drug Hypersensitivity; Humans; Lincomycin; Penicillin G; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1973 |
Clinical value of antistaphylococcal drugs.
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin | 1973 |
Penetration of antistaphylococcal antibiotics into the human eye.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Cephalosporins; Cephalothin; Eye; Gentamicins; Humans; Methicillin; Middle Aged; Nafcillin; Staphylococcal Infections; Staphylococcus; Sulfides; Tetrazoles; Thiadiazoles; Vancomycin | 1974 |
Antimicrobial considerations in anaerobic infections.
Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella | 1974 |
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.
Topics: Anti-Bacterial Agents; Bacitracin; Cephalosporins; Chloramphenicol; Enterococcus faecalis; Erythromycin; Gentamicins; Kanamycin; Lincomycin; Microbial Sensitivity Tests; Novobiocin; Penicillin Resistance; Penicillins; Species Specificity; Streptococcus; Streptomycin; Tetracycline; Vancomycin | 1969 |
[Kinetic specification of some antibiotics in cases with kidney insufficiency].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Erythromycin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Oxacillin; Penicillins; Streptomycin; Tetracycline; Vancomycin | 1972 |
Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Lincomycin; Lysostaphin; Methicillin; Novobiocin; Penicillin Resistance; Penicillins; Staphylococcus; Tetracycline; Vancomycin | 1968 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.
Topics: Agar; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Culture Media; Erythromycin; Humans; Lincomycin; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Staphylococcus; Streptococcus; Tetracycline; Vancomycin | 1970 |
Biosynthesis of the peptidoglycan of bacterial cell walls. XII. Inhibition of cross-linking by penicillins and cephalosporins: studies in Staphylococcus aureus in vivo.
Topics: Ampicillin; Bacitracin; Carbon Isotopes; Cell Wall; Cephalosporins; Chromatography, Gel; Chromatography, Thin Layer; Depression, Chemical; Glycine; Methicillin; Penicillin G; Penicillins; Peptide Biosynthesis; Polysaccharides, Bacterial; Staphylococcus; Vancomycin | 1968 |
Antimicrobial therapy of childhood skeletal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Arthritis, Infectious; Bone Diseases; Cephalosporins; Child; Chloramphenicol; Clindamycin; Humans; Infections; Penicillins; Vancomycin | 1984 |
Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis.
Topics: Cephalosporins; Endocarditis, Bacterial; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Vancomycin | 1983 |
Antimicrobial tolerance in group C and group G streptococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus; Vancomycin | 1984 |
Use of antibiotics in dental practice.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Cephalosporins; Clindamycin; Dental Care; Erythromycin; Humans; Penicillin Resistance; Penicillins; Streptomycin; Tetracyclines; Vancomycin | 1984 |
Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin | 1984 |
Antibiotic-associated pseudomembranous colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Guinea Pigs; Humans; Intestines; Staphylococcal Infections; Vancomycin | 1981 |
Alternative antibiotics for the penicillin-sensitive patient.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Erythromycin; Hospitalization; Humans; Microbial Sensitivity Tests; Penicillins; Skin Tests; Tetracyclines; Vancomycin | 1981 |
Bacitracin therapy in antibiotic-associated pseudomembranous colitis.
Topics: Adult; Ampicillin; Bacitracin; Cephalosporins; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Male; Penicillin Resistance; Urinary Tract Infections; Vancomycin | 1980 |
[Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin | 1982 |
Treatment of penicillin-sensitive streptococcal infective endocarditis.
Topics: Adult; Aged; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Penicillin G; Penicillin G Procaine; Streptococcal Infections; Streptomycin; Vancomycin | 1982 |
Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
The emergence of methicillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Humans; Methicillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Antimicrobial therapy of streptococcal endocarditis.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Penicillin G; Streptococcal Infections; Streptomycin; Vancomycin | 1982 |
[Resistant pneumococcal meningitis revealing sickle cell anemia: efficacy of cefotaxime-vancomycin combination].
Topics: Anemia, Sickle Cell; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Penicillin Resistance; Vancomycin | 1995 |
Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.
Topics: Base Sequence; Cefotaxime; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Meningitis, Pneumococcal; Molecular Sequence Data; Penicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1995 |
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin | 1995 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Clostridium difficile colitis: an increasing hospital-acquired illness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin | 1995 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Neutropenia; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus; Vancomycin | 1994 |
Caution in the use of commercial serum.
Topics: Animals; Blood; Blood Preservation; Cephalosporins; Mice; Microbial Sensitivity Tests; Minocycline; Quality Control; Rabbits; Reproducibility of Results; Vancomycin | 1994 |
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
Topics: beta-Lactamase Inhibitors; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1994 |
[Purulent meningitis in infants. Is it urgent to modify the treatment of first choice?].
Topics: Cephalosporins; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Vancomycin | 1994 |
Column-switching high-performance liquid chromatographic determination of vancomycin in serum.
Topics: Autoanalysis; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Immunoenzyme Techniques; Vancomycin | 1994 |
Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci.
Topics: Cephalosporins; Child; Humans; Meningitis, Pneumococcal; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1994 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Empiric treatment of endophthalmitis. Are aminoglycosides necessary?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Ceftazidime; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Postoperative Complications; Vancomycin | 1994 |
Fever and neutropenia during intensive chemotherapy.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pseudomonas Infections; Vancomycin | 1993 |
Epileptogenic effect of antibiotic drugs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Clindamycin; Electroencephalography; Epilepsy; Erythromycin; Hippocampus; Humans; In Vitro Techniques; Penicillins; Rats; Rats, Wistar; Vancomycin | 1993 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftriaxone; Cephalosporins; Dexamethasone; Drug Synergism; Female; Meningitis, Pneumococcal; Rabbits; Vancomycin | 1995 |
Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Topics: Anemia, Sickle Cell; Bacteremia; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1995 |
Comparative treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefazolin; Cephalosporins; Combined Modality Therapy; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Methylprednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitrectomy; Vitreous Body | 1996 |
Epidural abscess--early magnetic resonance imaging detection and conservative therapy.
Topics: Abscess; Adult; Analgesia, Epidural; Anti-Bacterial Agents; Catheters, Indwelling; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Epidural Space; Female; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Spinal Diseases; Vancomycin | 1996 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
Extraintestinal Clostridium difficile infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Bacteremia; Ceftazidime; Cephalosporins; Clostridioides difficile; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Vancomycin; Wounds and Injuries | 1996 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
[Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Synergism; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1996 |
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Time Factors; Vancomycin | 1996 |
Risk factors for mortality associated with enterococcal bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; United States; Vancomycin | 1996 |
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mycobacterium tuberculosis; Pneumococcal Infections; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; Vancomycin | 1996 |
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1996 |
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1996 |
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
Topics: Animals; Anti-Bacterial Agents; Borrelia; Borrelia burgdorferi Group; Brain; Ceftriaxone; Cephalosporins; Injections, Subcutaneous; Lyme Disease; Mice; Mice, Inbred BALB C; Mice, SCID; Microbial Sensitivity Tests; Relapsing Fever; Vancomycin | 1996 |
Effect of cefazolin and vancomycin on osteoblasts in vitro.
Topics: Anti-Bacterial Agents; Cefazolin; Cell Death; Cell Division; Cephalosporins; Dose-Response Relationship, Drug; Humans; Osteoblasts; Tumor Cells, Cultured; Vancomycin | 1996 |
In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Therapy, Combination; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1996 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Half-Life; Lung; Male; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rats; Rats, Wistar; Streptococcus pneumoniae; Vancomycin | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child, Preschool; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meningitis, Bacterial; Vancomycin | 1997 |
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin | 1997 |
Staphylococcal meningitis secondary to sacral osteomyelitis in an infant.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Female; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Bacterial; Osteomyelitis; Sacrum; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 1997 |
[Studies on enrichment broth for verotoxin-producing Escherichia coli (VTEC) O157].
Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli O157; Novobiocin; Pseudomonas; Shiga Toxin 1; Tellurium; Temperature; Vancomycin | 1997 |
In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Kinetics; Microbial Sensitivity Tests; Streptococcus pneumoniae; Vancomycin | 1996 |
Antibiotic prophylaxis for hemodialysis access placement.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arteriovenous Shunt, Surgical; Bacterial Infections; Cefazolin; Cephalosporins; Humans; Renal Dialysis; Vancomycin | 1997 |
Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1997 |
Antimicrobial prophylaxis in surgery.
Topics: Anti-Bacterial Agents; Bites and Stings; Cardiac Surgical Procedures; Cefazolin; Cephalosporins; Digestive System Surgical Procedures; Drug Administration Schedule; Fractures, Bone; Head; Humans; Hysterectomy, Vaginal; Methicillin Resistance; Neck; Neurosurgical Procedures; Ophthalmologic Surgical Procedures; Orthopedic Procedures; Staphylococcus; Surgical Procedures, Operative; Surgical Wound Infection; Thoracic Surgical Procedures; Urologic Surgical Procedures; Vancomycin; Vascular Surgical Procedures | 1997 |
[Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 1997 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
Antibiotic prophylaxis in cataract operations.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefazolin; Cephalosporins; Drug Resistance, Microbial; Humans; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Management of endophthalmitis in a silicone oil-filled eye.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Laser Coagulation; Male; Middle Aged; Postoperative Complications; Retinal Detachment; Silicone Oils; Staphylococcal Infections; Vancomycin; Vitrectomy | 1997 |
Penicillin-resistant pneumococcal meningitis in Israel.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Humans; Infant; Israel; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Vancomycin | 1997 |
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Erythromycin; Humans; Penicillins; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Extrusion of an anterior chamber intraocular lens complicated by Haemophilus endophthalmitis.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Foreign-Body Migration; Haemophilus Infections; Haemophilus influenzae; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Vancomycin; Vitrectomy; Vitreous Body | 1998 |
Storage of extemporaneously prepared ophthalmic antimicrobial solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Drug Compounding; Drug Storage; Ophthalmic Solutions; Tobramycin; Vancomycin | 1998 |
[Sickle cell anemia patients in oral medicine. What treatment? Apropos of a case and review of the literature].
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Female; Humans; Incisor; Maxillary Diseases; Odontogenic Cysts; Pneumonia, Pneumococcal; Postoperative Complications; Root Canal Therapy; Tooth Fractures; Vancomycin | 1998 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Drug Synergism; Fluoroquinolones; Humans; Naphthyridines; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin | 1998 |
Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Drug Resistance, Microbial; Enterococcus faecium; Hospitals, Teaching; Humans; Infection Control; Methicillin; Methicillin Resistance; New York; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Surgical site infections after coronary artery bypass surgery, with special reference to antibiotic prophylaxis and risk factors.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Female; Humans; Male; Risk Factors; Surgical Wound Infection; Vancomycin | 1998 |
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Cephalosporins; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Enteral Nutrition; Enterococcus; Female; Humans; Infection Control; Male; Middle Aged; Proportional Hazards Models; Risk; Risk Factors; Vancomycin | 1998 |
In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1998 |
Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children.
Topics: Adolescent; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Vancomycin | 1998 |
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Metabolic Clearance Rate; Methicillin Resistance; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcus; Vancomycin; Wound Infection | 1998 |
Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cephalosporins; Male; Microbial Sensitivity Tests; Osteomyelitis; Predictive Value of Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1998 |
Quantitation of vancomycin and its crystalline degradation product (CDP-1) in human serum by high performance liquid chromatography.
Topics: Cefazolin; Cephalosporins; Chromatography, High Pressure Liquid; Crystallization; Humans; Isomerism; Kidney Diseases; Reference Standards; Vancomycin | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Are we asking for trouble?
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Prescriptions; Drug Resistance, Microbial; Drug Therapy, Combination; Empiricism; Humans; Meningitis, Pneumococcal; Vancomycin | 1998 |
Low postoperative infection rates with instrumented lumbar fusion.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Transplantation; Cefazolin; Cephalosporins; Child; Debridement; Drug Therapy, Combination; Female; Gentamicins; Humans; Incidence; Internal Fixators; Lumbar Vertebrae; Male; Middle Aged; Retrospective Studies; Risk Factors; Spinal Fusion; Surgical Wound Infection; Therapeutic Irrigation; Time Factors; Vancomycin | 1998 |
Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Multivariate Analysis; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Dialysis Solutions; Drug Compounding; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Temperature; Vancomycin | 1999 |
Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.
Topics: Animals; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 1998 |
Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephalothin; Coagulase; Genes, Bacterial; Humans; Infant; Infant, Newborn; Methicillin Resistance; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1999 |
Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
Topics: Acitretin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Psoriasis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1999 |
Nosocomial meningitis in children after ventriculoperitoneal shunt insertion.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Ventriculoperitoneal Shunt | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Lung; Male; Pneumonia, Pneumococcal; Radiography; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1999 |
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 1999 |
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievab
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cephalosporin Resistance; Cephalosporins; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Streptococcus pneumoniae; Vancomycin | 1999 |
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin | 1999 |
Safety of repeated intravitreous injections of antibiotics and dexamethasone.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cell Count; Cephalosporins; Dexamethasone; Drug Combinations; Electroretinography; Glucocorticoids; Half-Life; Injections; Ophthalmoscopy; Rabbits; Retina; Safety; Vancomycin; Vitreous Body | 1999 |
Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.
Topics: Bacteriolysis; Cephalosporins; Female; Head; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Recurrence; Spine; Tomography; Vancomycin; Vancomycin Resistance | 2000 |
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Pneumococcal; Middle Aged; Population Surveillance; Risk Factors; Streptococcus pneumoniae; Vancomycin | 2000 |
Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Drug Evaluation, Preclinical; Drug Therapy, Combination; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Vancomycin | 2000 |
Rationing antibiotic use in neonatal units.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Decision Making; Drug Resistance, Microbial; Floxacillin; Health Care Rationing; Humans; Infant, Newborn; Intensive Care, Neonatal; Penicillins; Sepsis; Vancomycin | 2000 |
Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Hypersensitivity; Drug Interactions; Exanthema; Female; Fever; Humans; Pancytopenia; Vancomycin | 2000 |
Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
Topics: Animals; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1999 |
Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiovascular Surgical Procedures; Cefazolin; Cephalosporins; Cost-Benefit Analysis; Decision Trees; Drug Hypersensitivity; Humans; Immunoglobulin E; Penicillins; Skin Tests; Vancomycin; Vancomycin Resistance | 2000 |
In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Female; Leukopenia; Lung; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Serum Bactericidal Test; Streptococcus pneumoniae; Survival Analysis; Vancomycin | 2000 |
Beware of short-course therapy for Staphylococcus aureus bacteremia without a removable cause.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Cefazolin; Cephalosporins; Clavulanic Acids; Discitis; Drug Therapy, Combination; Enzyme Inhibitors; Epidural Abscess; Follow-Up Studies; Foot Diseases; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Ticarcillin; Vancomycin | 2000 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
Methicillin-resistant Staphylococcus aureus infections in 2 pediatric outpatients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephalosporins; Child; Clindamycin; Community-Acquired Infections; Drainage; Female; Hospitalization; Humans; Infant; Methicillin Resistance; Neck; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Failure; Vancomycin | 2000 |
Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective.
Topics: Algorithms; Anti-Bacterial Agents; Australia; Catheterization; Cephalosporins; Humans; New Zealand; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Vancomycin | 1999 |
Effects of very high antibiotic concentrations on human intervertebral disc cell proliferation, viability, and metabolism in vitro.
Topics: Adult; Cell Division; Cell Survival; Cells, Cultured; Cephalosporins; Dose-Response Relationship, Drug; Energy Metabolism; Female; Gentamicins; Humans; Hydrogen-Ion Concentration; Infant; Intervertebral Disc; Male; Middle Aged; Thymidine; Trypan Blue; Vancomycin | 2000 |
Infection related to intracranial pressure monitors in adults: analysis of risk factors and antibiotic prophylaxis.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheterization; Cefazolin; Central Nervous System Diseases; Cephalosporins; Cerebrospinal Fluid; Cohort Studies; Female; Humans; Infections; Intracranial Pressure; Male; Middle Aged; Monitoring, Physiologic; Retrospective Studies; Risk Factors; Vancomycin; Ventriculostomy | 2000 |
Solitary hepatic abscess with associated glomerulonephritis in a neonate.
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Drainage; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Infant, Newborn; Liver Diseases; Magnetic Resonance Imaging; Micrococcus; Staphylococcal Infections; Vancomycin | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin | 2001 |
[Alpha-1-antitrypsin in early infections after hip prosthesis surgery].
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Sedimentation; C-Reactive Protein; Cefamandole; Cephalosporins; Clinical Enzyme Tests; Data Interpretation, Statistical; Female; Hip Prosthesis; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Postoperative Care; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Tobramycin; Vancomycin | 2000 |
In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Synergism; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin | 2001 |
In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefamandole; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Serum Bactericidal Test; Staphylococcus aureus; Teicoplanin; Vancomycin | 1999 |
Invasive pneumococcal disease.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Diagnosis, Differential; Echocardiography, Transesophageal; Erythromycin; Female; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Penicillins; Pneumococcal Infections; Radiography, Thoracic; Streptococcus pneumoniae; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2001 |
[Isolation and drug susceptibility of Staphylococcus epidermidis from respiratory tract].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1998 |
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Equipment Contamination; Female; Gentamicins; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pseudomonas Infections; Retrospective Studies; Secondary Prevention; Vancomycin | 2001 |
In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
[Antibiotic chemoprophylaxis in orthopedic prosthesis implantation].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Drug Administration Schedule; Elective Surgical Procedures; Humans; Methicillin Resistance; Orthopedic Procedures; Surgical Wound Infection; Teicoplanin; Vancomycin | 2000 |
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Topics: Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Humans; Infusions, Intravenous; Midazolam; Nicardipine; Pneumonia, Bacterial; Propofol; Temperature; Vancomycin | 2001 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Synergism; Enterococcus faecalis; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Vancomycin | 2001 |
Multi-hospital analysis of antimicrobial usage and resistance trends.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Bacterial; Enterobacter; Enterococcus; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Legislation, Hospital; Methicillin Resistance; Penicillins; Pilot Projects; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2001 |
Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Disease Outbreaks; Female; Humans; Male; Middle Aged; Vancomycin | 2001 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.
Topics: Anti-Bacterial Agents; Biological Availability; Body Temperature; Ceftazidime; Cephalosporins; Chemical Precipitation; Chromatography, High Pressure Liquid; Dialysis; Dialysis Solutions; Drug Combinations; Drug Stability; Endophthalmitis; Eye Infections, Bacterial; Humans; Hydrogen-Ion Concentration; Ophthalmic Solutions; Vancomycin; Vitreous Body | 2002 |
Klebsiella pneumoniae brain abscess in a Taiwanese adult.
Topics: Acyclovir; Brain Abscess; Cefepime; Cephalosporins; Ethnicity; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Taiwan; Vancomycin | 2002 |
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Cephalosporins; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Metronidazole; Middle Aged; Risk Factors; Vancomycin; Vancomycin Resistance | 2002 |
Multiple embolism in a female patient with infective endocarditis. Low back pain and hematuria as the initial clinical manifestations.
Topics: Amikacin; Ceftriaxone; Cephalosporins; Embolism; Endocarditis, Bacterial; Female; Hematuria; Humans; Low Back Pain; Middle Aged; Mitral Valve Prolapse; Streptococcus; Vancomycin | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study.
Topics: Adolescent; Age Distribution; Canada; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Logistic Models; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Multivariate Analysis; Penicillin Resistance; Reference Values; Retrospective Studies; Rifampin; Risk Assessment; Sex Distribution; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2002 |
Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Systemic Inflammatory Response Syndrome; Vancomycin | 2002 |
In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.
Topics: Animals; Area Under Curve; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Half-Life; Injections, Subcutaneous; Male; Mice; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Vancomycin | 2003 |
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.
Topics: Cephalosporins; Clindamycin; Drug Prescriptions; Drug Utilization; Enterococcus; Humans; Microbial Sensitivity Tests; Statistics as Topic; Vancomycin; Vancomycin Resistance | 2003 |
In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; In Vitro Techniques; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2003 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Environment; Gram-Negative Bacteria; Gram-Positive Bacteria; Household Products; Microbial Sensitivity Tests; Oxacillin; Plant Oils; Random Allocation; Soil Microbiology; Triclosan; Vancomycin; Xylenes | 2003 |
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Colony Count, Microbial; Daptomycin; Dialysis Solutions; Hydrogen-Ion Concentration; Methicillin Resistance; Peritoneal Dialysis; Peritonitis; Protein Binding; Staphylococcus; Streptococcus; Vancomycin | 2003 |
Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus faecium; Humans; Imipenem; Klebsiella pneumoniae; Korea; Pseudomonas aeruginosa; Time Factors; Vancomycin | 2004 |
Spontaneous corynebacterium discitis in a patient with chronic renal failure.
Topics: Anti-Bacterial Agents; Cephalosporins; Corynebacterium diphtheriae; Corynebacterium Infections; Diagnosis, Differential; Discitis; Diskectomy; Humans; Kidney Failure, Chronic; Low Back Pain; Lumbosacral Region; Magnetic Resonance Imaging; Male; Middle Aged; Rifampin; Vancomycin | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Drug Carriers; Durapatite; Female; Femur; Gentamicins; Microscopy, Electron, Scanning; Nanostructures; Porosity; Prostheses and Implants; Rabbits; Vancomycin | 2004 |
Left atrial myxoma prolapsing into the left ventricle. Case report and review of the literature.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cloxacillin; Combined Modality Therapy; Diagnosis, Differential; Echocardiography, Transesophageal; Gentamicins; Heart Atria; Heart Neoplasms; Heart Ventricles; Humans; Male; Middle Aged; Myxoma; Netilmicin; Streptococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin; Viridans Streptococci | 2004 |
Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Topics: Animals; Aortic Valve; Cephalosporins; Disease Models, Animal; Endocarditis, Bacterial; Heart Valve Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Are cephalosporins adequate for antimicrobial prophylaxis for cardiac surgery involving implants?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cephalosporins; Heart Valves; Humans; Methicillin Resistance; Practice Guidelines as Topic; Prosthesis-Related Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2005 |
Epidural abscess following epidural analgesia in pediatric patients.
Topics: Analgesia, Epidural; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Epidural Abscess; Female; Fundoplication; Humans; Infant; Magnetic Resonance Imaging; Male; Reflex Sympathetic Dystrophy; Spinal Cord; Streptococcal Infections; Vancomycin | 2005 |
Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Cephalosporins; Foreign Bodies; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis.
Topics: Acyclovir; Ampicillin; Calcification, Physiologic; Cefepime; Cephalosporins; Community-Acquired Infections; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Humans; Meningitis, Bacterial; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2005 |
Pneumococcal meningitis and otitis media.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child; Dexamethasone; Humans; Leukocyte Count; Meningitis, Pneumococcal; Otitis Media; Penicillin Resistance; Retrospective Studies; Vancomycin | 2006 |
Case of the month. Chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Biopsy; Cefepime; Cephalosporins; Chronic Disease; Humans; Humerus; Male; Osteomyelitis; Recurrence; Vancomycin | 2005 |
Clinical outcomes of penicillin skin testing.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Penicillins; Practice Patterns, Physicians'; Retrospective Studies; Skin Tests; Vancomycin | 2005 |
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Lymphoma; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Autologous; Vancomycin | 2006 |
Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Wall; Cephalosporins; Circular Dichroism; Cloning, Molecular; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Kinetics; Methicillin; Methicillin Resistance; Models, Chemical; Molecular Conformation; Penicillin-Binding Proteins; Protein Binding; Protein Conformation; Staphylococcus aureus; Time Factors; Ultraviolet Rays; Vancomycin | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Three-year analysis of microbial aetiology and antimicrobial susceptibilities of PD peritonitis.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Dialysis Solutions; Female; Glucans; Glucose; Humans; Icodextrin; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Tobramycin; Vancomycin | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
Simultaneous determination of cefepime and vancomycin in plasma and cerebrospinal fluid by MEKC with direct sample injection and application for bacterial meningitis.
Topics: Buffers; Cefepime; Cephalosporins; Chromatography, Micellar Electrokinetic Capillary; Humans; Hydrogen-Ion Concentration; Meningitis, Bacterial; Sodium Dodecyl Sulfate; Tromethamine; Vancomycin | 2007 |
An antibiotic-inducible cell wall-associated protein that protects Bacillus subtilis from autolysis.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cell Wall; Cephalosporins; Cycloserine; Drug Resistance, Bacterial; Fosfomycin; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Sequence Alignment; Succinate Dehydrogenase; Time Factors; Vancomycin | 2007 |
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Ceftaroline; Cephalosporins; Chromatography, High Pressure Liquid; Colony Count, Microbial; Endocarditis, Bacterial; Immunoenzyme Techniques; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2007 |
Treatment of septic arthritis.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefazolin; Cephalosporins; Gentamicins; Gonorrhea; Humans; Methicillin Resistance; Vancomycin | 2007 |
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin | 2007 |
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin | 2007 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; France; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Infant; Infant, Newborn; Male; Meningitis, Pneumococcal; Meningococcal Vaccines; Penicillin Resistance; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Vancomycin | 2008 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria | 2008 |
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Renal Dialysis; Thrombocytopenia; Vancomycin | 2008 |
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Fever, hip pain, and headache in a 12-year-old girl.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Diagnosis, Differential; Drug Therapy, Combination; Female; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Headache; Hip; Humans; Magnetic Resonance Imaging; Meropenem; Thienamycins; Tomography, X-Ray Computed; Vancomycin | 2008 |
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ascites; Cephalosporins; Cohort Studies; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Korea; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
Cefepime-induced neutropenia in a teenager.
Topics: Accidents, Traffic; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Neutropenia; Serratia Infections; Serratia marcescens; Spinal Fractures; Spinal Fusion; Surgical Wound Infection; Vancomycin | 2008 |
Acute bacterial meningitis caused by Streptococcus pneumoniae resistant to the antimicrobian agents and their serotypes.
Topics: Acute Disease; Adolescent; Aged; Anti-Bacterial Agents; Brazil; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Pneumococcal; Middle Aged; Penicillins; Risk Factors; Serotyping; Statistics, Nonparametric; Streptococcus pneumoniae; Vancomycin; Young Adult | 2008 |
Clinical features and outcome analysis of 90 cases with brain abscess in central China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Brain; Brain Abscess; Cephalosporins; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intravenous; Injections, Spinal; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2008 |
[Intravitreal injection of antibiotics in endophthalmitis].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Humans; Injections; Retinal Detachment; Vancomycin; Vitrectomy; Vitreous Body | 2008 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Skin Diseases, Infectious; Treatment Outcome; Vancomycin | 2009 |
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
Topics: Animals; Anti-Bacterial Agents; Bombyx; Cephalosporins; Chloramphenicol; Cycloserine; Inhibitory Concentration 50; Larva; Microbial Sensitivity Tests; Staphylococcus aureus; Tetracycline; Vancomycin | 2009 |
Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.
Topics: Aged; Anti-Bacterial Agents; Australia; Cephalosporins; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Cephalosporins; Confidence Intervals; Decision Support Techniques; Drug Therapy, Combination; Glycopeptides; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Odds Ratio; Quality-Adjusted Life Years; Staphylococcal Infections; Surgical Wound Infection; United Kingdom; Vancomycin | 2010 |
In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2009 |
In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and van
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Enterococcus faecalis; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Vancomycin; Vancomycin Resistance | 2009 |
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin | 2010 |
A 10-month-old boy with 'total body swelling'.
Topics: Anti-Bacterial Agents; Breast Feeding; Cephalosporins; Eosinophilia; Gastroenteritis; Humans; Hypoalbuminemia; Immunologic Deficiency Syndromes; Infant; Intertrigo; Male; Meningitis, Pneumococcal; Vancomycin | 2009 |
Clinical behavior of Streptococcus pneumoniae meningoencephalitis.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Cross-Sectional Studies; Humans; Infant; Meningoencephalitis; Pneumococcal Infections; Prospective Studies; Streptococcus pneumoniae; Vancomycin | 2009 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates.
Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2010 |
Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cephalosporins; Cognition Disorders; Community-Acquired Infections; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Penicillin Resistance; Prevalence; Republic of Korea; Retrospective Studies; Vancomycin; Young Adult | 2010 |
Ceftobiprole: Farewell or just a delay?
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Approval; Humans; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; United States; United States Food and Drug Administration; Vancomycin | 2010 |
Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation.
Topics: Acinetobacter Infections; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Cefepime; Cephalosporins; Diagnosis, Differential; Endocarditis, Bacterial; Female; Heart Atria; Humans; Kidney Failure, Chronic; Ofloxacin; Ultrasonography; Vancomycin | 2010 |
Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone and Bones; Bone Marrow; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxazolidinones; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucositis; Pharynx; Risk Factors; Transplantation, Homologous; Vancomycin; Young Adult | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.
Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Cephalosporins; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Female; Humans; Rifampin; Syndrome; Vancomycin | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
Septic elbow in the setting of neuropathic joint as the initial presentation of a cervical syrinx.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Arthropathy, Neurogenic; Cefepime; Cephalosporins; Cervical Vertebrae; Elbow Joint; Humans; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Syringomyelia; Treatment Refusal; Vancomycin | 2011 |
Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacitracin; Biofilms; Cefazolin; Cephalosporins; Clindamycin; Device Removal; Disinfection; Gentamicins; Gram-Positive Bacterial Infections; Humans; Joint Prosthesis; Penicillins; Peptostreptococcus; Peroxides; Povidone-Iodine; Practice Guidelines as Topic; Practice Patterns, Dentists'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temporomandibular Joint; Therapeutic Irrigation; Vancomycin | 2011 |
Rare case of large double perforated anterior mitral leaflet pseudoaneurysm in a patient with aortic valve endocarditis.
Topics: Aged; Aneurysm, False; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cefepime; Cephalosporins; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Endocarditis, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Tricuspid Valve Insufficiency; Vancomycin | 2011 |
Prophylactic antibiotics in orthopaedic surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Arthroscopy; Cephalosporins; Hand; Humans; Methicillin-Resistant Staphylococcus aureus; Orthopedic Procedures; Spinal Diseases; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Endocarditis; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Colony Count, Microbial; Dimerization; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycopeptides; Humans; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Thigh; Vancomycin | 2012 |
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic.
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2012 |
Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Dosage Calculations; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cephalosporins; Colony Count, Microbial; Corynebacterium; Culture Media; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin | 2012 |
Early endpoints for acute bacterial skin and skin structure infections.
Topics: Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Female; Humans; Male; Skin Diseases, Bacterial; Vancomycin | 2012 |
Cervical osteomyelitis after placement of a self-expanding plastic stent for palliation of dysphagia associated with chemoradiation-induced esophageal strictures.
Topics: Anti-Bacterial Agents; Carcinoma, Squamous Cell; Cefepime; Cephalosporins; Chemoradiotherapy, Adjuvant; Deglutition Disorders; Esophageal Stenosis; Humans; Male; Middle Aged; Osteomyelitis; Palliative Care; Pharyngeal Neoplasms; Stents; Vancomycin | 2013 |
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
Topics: Academic Medical Centers; Adolescent; Anti-Infective Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Utilization; Drug Utilization Review; Female; Hospitals, Pediatric; Humans; Inappropriate Prescribing; Infant; Infant, Newborn; Male; Minnesota; Prescription Drugs; Retrospective Studies; Vancomycin | 2012 |
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
Topics: Age Factors; Aztreonam; Bacterial Toxins; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Exotoxins; Female; Genotype; Humans; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2012 |
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Ceftaroline; Cell Membrane; Cell Wall; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Drug Synergism; Fluorescent Dyes; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Models, Biological; Mutation; Vancomycin; Vancomycin Resistance | 2013 |
Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance | 2012 |
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin | 2013 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Debridement; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2013 |
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.
Topics: Anti-Bacterial Agents; Boron Compounds; Ceftaroline; Cell Wall; Cephalosporins; Drug Combinations; Drug Synergism; Fluorescent Dyes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Vancomycin Resistance | 2013 |
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Coronary Artery Bypass; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; United States; Vancomycin | 2013 |
Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic/pharmacodynamic model: exploring the "seesaw effect
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2013 |
A unique case of peroneus brevis/longus myositis in a patient with a STAT3 mutation.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Disease-Free Survival; Humans; Job Syndrome; Male; Muscles; Mutation; Myositis; Recurrence; STAT3 Transcription Factor; Vancomycin | 2013 |
Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Clostridioides difficile; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prednisone; Radiography; Rituximab; Typhlitis; Vancomycin; Vincristine | 2013 |
Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Vancomycin | 2012 |
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Costs and Cost Analysis; Drug Therapy, Combination; Economics, Hospital; Formularies, Hospital as Topic; Humans; Length of Stay; Models, Economic; Skin Diseases, Bacterial; Vancomycin | 2013 |
Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger; RNA, Small Untranslated; Sequence Analysis, RNA; Tigecycline; Transcription, Genetic; Vancomycin | 2013 |
No need for broad-spectrum empirical antibiotic coverage after surgical drainage of orthopaedic implant infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cohort Studies; Drainage; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Penicillins; Prosthesis-Related Infections; Regression Analysis; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines.
Topics: Adult; Bacterial Toxins; Carbuncle; Cephalosporins; Community-Acquired Infections; Exotoxins; Female; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Philippines; Republic of Korea; Staphylococcal Skin Infections; Travel; Vancomycin | 2013 |
Evaluation of the effect of serum proteins on the antibacterial activity and pharmacodynamics of ceftaroline against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Blood Proteins; Ceftaroline; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Protein Binding; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefepime; Cefuroxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Factors; Toll-Like Receptor 4; Vancomycin | 2013 |
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Diabetes Complications; Drug Therapy, Combination; Humans; Incidence; Middle Aged; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Mortality indicators in pneumococcal meningitis: therapeutic implications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Retrospective Studies; Treatment Outcome; Turkey; Vancomycin; Young Adult | 2014 |
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Vancomycin; Vancomycin Resistance | 2014 |
Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; United States; Vancomycin; Vancomycin Resistance | 2014 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Perioperative antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthritis, Infectious; Arthroplasty, Replacement; Cephalosporins; Contraindications; Heart Valve Prosthesis; Humans; Postoperative Care; Prosthesis-Related Infections; Reoperation; Urinary Catheterization; Urinary Tract Infections; Vancomycin | 2014 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Ceftaroline-heteroresistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Computer Simulation; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2014 |
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Candidiasis; Cefepime; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Ciprofloxacin; Consolidation Chemotherapy; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Incidence; Induction Chemotherapy; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Neoplasm Staging; Nose; Outpatients; Rectum; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2014 |
Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Variation in antibiotic prophylaxis selection for coronary artery bypass graft procedures in an era of increasing methicillin-resistant Staphylococcus aureus prevalence.
Topics: Antibiotic Prophylaxis; California; Cephalosporins; Coronary Artery Bypass; Databases, Factual; Drug Therapy, Combination; Drug Utilization; Health Care Surveys; Humans; Methicillin-Resistant Staphylococcus aureus; Practice Patterns, Physicians'; Staphylococcal Infections; Vancomycin | 2014 |
Microbacterium spp. as a cause of peritoneal-dialysis-related peritonitis in two patients.
Topics: Acinetobacter; Actinobacteria; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peritoneal Dialysis; Peritonitis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2016 |
Selective pharmacologic inhibition of a PASTA kinase increases Listeria monocytogenes susceptibility to β-lactam antibiotics.
Topics: Anti-Bacterial Agents; Cell Wall; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gene Deletion; Imidazoles; Listeria monocytogenes; Penicillin-Binding Proteins; Penicillins; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Staurosporine; Vancomycin | 2014 |
[Peritoneal dialysis-related infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheters, Indwelling; Cephalosporins; Drug Therapy, Combination; Humans; Patient Education as Topic; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Disease Models, Animal; Drug Resistance, Bacterial; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Vancomycin | 2014 |
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ceftaroline; Cephalosporins; Demography; Disease Eradication; Female; Glycopeptides; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Treatment Failure; Vancomycin | 2014 |
In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Area Under Curve; Biomimetic Materials; Ceftaroline; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Extracellular Fluid; Humans; Methicillin-Resistant Staphylococcus aureus; Models, Statistical; Respiratory Mucosa; Vancomycin | 2014 |
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Drug Tolerance; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections; Vancomycin | 2015 |
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].
Topics: Aztreonam; Ceftaroline; Cephalosporins; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
Images in emergency medicine. Acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Middle Aged; Vancomycin | 2015 |
Trust me, this is the worst "acne" of your life!
Topics: Acute Generalized Exanthematous Pustulosis; Anti-Bacterial Agents; Cefepime; Cephalosporins; Diagnosis, Differential; Drug Eruptions; Female; Humans; Middle Aged; Vancomycin | 2015 |
Impact of Clostridium difficile recurrence on hospital readmissions.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin | 2015 |
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Incompatibility; Drug Stability; Infusions, Intravenous; Infusions, Parenteral; Reference Standards; Vancomycin | 2015 |
X-linked agammaglobulinemia in a child conceived using a donor egg: a medicolegal quandary.
Topics: Access to Information; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; B-Lymphocytes; Cefepime; Cephalosporins; Child, Preschool; Female; Genetic Diseases, X-Linked; Genetic Testing; Humans; Immunoglobulins, Intravenous; Infections; Male; Mutation; Pregnancy; Protein-Tyrosine Kinases; Tissue Donors; Vancomycin | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Mycotic pseudoaneurysm by vancomycin-intermediate Staphylococcus aureus: a rare cause of persistent bacteraemia.
Topics: Aneurysm, False; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Debridement; Diagnosis, Differential; Drug Resistance, Microbial; Femoral Artery; Humans; Ligation; Male; Middle Aged; Mycoses; Staphylococcus aureus; Thigh; Vancomycin; Venous Thrombosis | 2015 |
Gone but not forgotten: a case of respiratory distress.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cefdinir; Ceftriaxone; Cephalosporins; Child; Diagnosis, Differential; Dyspnea; Epiglottis; Epiglottitis; Humans; Intubation, Intratracheal; Male; Radiography; Vancomycin | 2015 |
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Topics: Anti-Bacterial Agents; Biofilms; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Half-Life; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2015 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Phototoxicity, Pseudoporphyria, and Photo-onycholysis Due to Voriconazole in a Pediatric Patient With Leukemia and Invasive Aspergillosis.
Topics: Ankle; Aspergillosis; Blister; Catheter-Related Infections; Cefepime; Cephalosporins; Cheilitis; Child; Cicatrix; Clindamycin; Dermatitis, Phototoxic; Echinocandins; Humans; Hypokalemia; Immunocompromised Host; Levofloxacin; Lipopeptides; Magnesium Deficiency; Male; Micafungin; Onycholysis; Photosensitivity Disorders; Porphyrias; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin; Voriconazole | 2015 |
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Fatal Outcome; Heart Valve Diseases; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Staphylococcal Infections; Tricuspid Valve; Vancomycin | 2015 |
Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Clostridium Infections; Coronary Artery Bypass; Databases, Factual; Drug Administration Schedule; Drug Therapy, Combination; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; Practice Patterns, Physicians'; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Vancomycin | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
[Combined intravenous and intrathecal vancomycin in treatment of patients with intracranial infections after craniotomy].
Topics: Central Nervous System Infections; Cephalosporins; Craniotomy; Humans; Injections, Intravenous; Injections, Spinal; Meropenem; Retrospective Studies; Thienamycins; Vancomycin | 2016 |
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin | 2017 |
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Disseminated Histoplasmosis with Skin Lesions and Osteomyelitis in a Patient from the Philippines.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amphotericin B; Cefepime; Cephalosporins; Dexamethasone; Follow-Up Studies; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Osteomyelitis; Philippines; Skin Diseases; Thalidomide; Vancomycin | 2016 |
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 2016 |
Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefdinir; Cephalosporins; Cytoskeletal Proteins; Drug Synergism; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2016 |
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Topics: Abiotrophia; Anti-Infective Agents; Carnobacteriaceae; Cefepime; Cefotaxime; Cephalosporins; Clindamycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Vancomycin | 2016 |
Pediatric invasive disease due to Haemophilus influenzae serogroup A in Riyadh, Saudi Arabia: case series.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Bacteriological Techniques; Cephalosporins; Cerebrospinal Fluid; Haemophilus influenzae; Haemophilus Vaccines; Humans; Infant; Male; Meningitis, Haemophilus; Saudi Arabia; Sepsis; Serogroup; Treatment Outcome; Vancomycin | 2016 |
Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2016 |
Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Genotype; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Staphylococcal Infections; Sweden; Vancomycin | 2016 |
Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Osteoarthritis; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Vancomycin | 2016 |
In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Topics: Aged; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Retrospective Studies; Risk; Severity of Illness Index; Vancomycin | 2017 |
Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Topics: Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Salvage Therapy; Staphylococcal Infections; Vancomycin | 2017 |
Aspergillus Terreus Brain Abscess Complicated by Tension Pneumocephalus in a Patient with Angiosarcoma.
Topics: Aged; Anti-Bacterial Agents; Aspergillosis; Aspergillus; Bacteremia; Brain Abscess; Cefepime; Cephalosporins; Disease Progression; Drug Combinations; Drug Therapy, Combination; Glucocorticoids; Hemangiosarcoma; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pneumocephalus; Proteus mirabilis; Skin Neoplasms; Staphylococcus aureus; Sulfamethizole; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim; Vancomycin; Voriconazole | 2017 |
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2016 |
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Female; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Michigan; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Glycopeptides; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Teicoplanin; Vancomycin | 2017 |
Requirement of the CroRS Two-Component System for Resistance to Cell Wall-Targeting Antimicrobials in Enterococcus faecium.
Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Cell Wall; Cephalosporins; Enterococcus faecalis; Enterococcus faecium; Gene Deletion; Microbial Sensitivity Tests; Protein Kinases; Signal Transduction; Trans-Activators; Vancomycin | 2017 |
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin | 2017 |
Antimicrobial salvage therapy for native valve MRSA endocarditis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Cytarabine; Female; Gram-Positive Bacterial Infections; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2017 |
Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Babesia microti infection and hemophagocytic lymphohistiocytosis in an immunocompetent patient.
Topics: Aged; Animals; Babesia microti; Babesiosis; Cefepime; Cephalosporins; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Minnesota; Ticks; Vancomycin | 2017 |
Successful treatment of community-acquired methicillin-resistant Staphylococcus aureus purulent myopericarditis.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Myocarditis; Pericardial Effusion; Pericardiectomy; Pericarditis; Postoperative Complications; Staphylococcal Infections; Steroids; Treatment Outcome; Vancomycin | 2017 |
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Topics: beta-Lactams; Cefazolin; Cefepime; Ceftaroline; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin | 2018 |
Determination of antimicrobial resistance to extended-spectrum cephalosporin, quinolones, and vancomycin in selected human enteric pathogens from Prince Edward Island, Canada.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Humans; Prince Edward Island; Quinolones; Vancomycin | 2018 |
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Female; Humans; Israel; Male; Metronidazole; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Secondary Prevention; Tertiary Care Centers; Vancomycin | 2018 |
Invasive pneumococcal disease in Indian adults: 11 years' experience.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Comorbidity; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; India; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Mortality; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Pneumonia; Prevalence; Prospective Studies; Serogroup; Streptococcus pneumoniae; Vaccines, Conjugate; Vancomycin; Young Adult | 2019 |
Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Meningitis, Bacterial; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Streptococcus pneumoniae; Vancomycin | 2019 |
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Genomics; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Staphylococcal Infections; Vancomycin | 2019 |
Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Ecological and Environmental Phenomena; Female; Fluoroquinolones; Hospitalization; Hospitals; Humans; Interrupted Time Series Analysis; Male; Metronidazole; Middle Aged; United States; Vancomycin | 2020 |
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2019 |
In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2020 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Male; Middle Aged; Retrospective Studies; Skin; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2019 |
Effect of Ceftaroline, Vancomycin, Gentamicin, Macrolides, and Ciprofloxacin against Methicillin-Resistant
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2020 |
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2020 |
Predictors for vancomycin resistant
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Case-Control Studies; Cephalosporins; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Vascular Access Devices | 2019 |
Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
Topics: Anti-Bacterial Agents; Bacteremia; Brazil; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model.
Topics: Animals; Ceftaroline; Cephalosporins; Meningitis; Methicillin-Resistant Staphylococcus aureus; Rabbits; Staphylococcal Infections; Vancomycin | 2020 |
Incidence of cystoid macular oedema with intracameral cephalosporin or vancomycin in cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Cephalosporins; Endophthalmitis; Female; Humans; Incidence; Injections, Intraocular; Macular Edema; Male; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Cephalosporins; Cross-Sectional Studies; Drug Therapy, Combination; Fluconazole; Heart-Assist Devices; Humans; Levofloxacin; Prosthesis Implantation; Prosthesis-Related Infections; Rifampin; Surgical Wound Infection; Surveys and Questionnaires; Vancomycin | 2020 |
Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult | 2020 |
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus.
Topics: Anti-Bacterial Agents; CD11b Antigen; Ceftaroline; Cephalosporins; Daptomycin; Humans; L-Selectin; Lipopolysaccharides; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin | 2020 |
High-level ceftaroline resistance in a paediatric patient with invasive methicillin-resistant Staphylococcus aureus infection without previous ceftaroline exposure.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Infant; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2021 |
Outcomes of Infectious Endophthalmitis in Patients with Systemic Antibiotic Allergies to Penicillins, Cephalosporins, or Vancomycin.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Treatment Outcome; Vancomycin | 2021 |
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Cephalosporins; Drug Hypersensitivity; Female; Humans; Hypovolemia; Male; Middle Aged; Penicillins; Periprosthetic Fractures; Postoperative Complications; Reoperation; Vancomycin | 2021 |
Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Teicoplanin; Vancomycin; Whole Genome Sequencing | 2021 |
Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Vancomycin | 2022 |
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Cystic Fibrosis; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Febrile Neutropenia; Fever; Humans; Retrospective Studies; Vancomycin | 2022 |
Cefotaxime-induced drug reaction with eosinophilia and systemic symptom in a child with cross-reactivity to other cephalosporins and cosensitization to teicoplanin.
Topics: Adult; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Male; Metronidazole; Teicoplanin; Vancomycin | 2023 |
Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
[Antibiotic use for prophylaxis and empirical therapy of fracture-related infections in Germany : A survey of 44 hospitals].
Topics: Anti-Bacterial Agents; Cephalosporins; Fracture Fixation, Internal; Fractures, Open; Hospitals; Humans; Meropenem; Penicillins; Surveys and Questionnaires; Vancomycin | 2023 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2023 |
Use of prophylactic perioperative antibiotics for lumbar spinal fusions: A nationwide population-based cohort study.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Humans; Retrospective Studies; Spinal Fusion; Vancomycin; Young Adult | 2023 |
Intrawound application of vancomycin reduces the proportion of fracture-related infections in high-risk tibial plateau fractures.
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Monobactams; Powders; Retrospective Studies; Surgical Wound Infection; Tibial Fractures; Tibial Plateau Fractures; Vancomycin | 2023 |
Intraosseous regional prophylaxis in total knee arthroplasty.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Cephalosporins; Humans; Prosthesis-Related Infections; Retrospective Studies; Vancomycin | 2023 |